capsaicin has been researched along with Neuralgia in 245 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (4.49) | 18.7374 |
| 1990's | 28 (11.43) | 18.2507 |
| 2000's | 28 (11.43) | 29.6817 |
| 2010's | 121 (49.39) | 24.3611 |
| 2020's | 57 (23.27) | 2.80 |
| Authors | Studies |
|---|---|
| Ann, J; Blumberg, PM; Choi, K; Esch, TE; Ha, HJ; Hwang, SW; Kim, H; Kim, HS; Kim, M; Kim, YH; Lee, J; Pearce, LV; Thorat, SA; Turcios, NA | 1 |
| Chun, J; Cincilla, G; Del Valle, CR; Devesa, I; Ferrer-Montiel, AV; González-Gil, I; Hernández-Torres, G; Khiar-Fernández, N; Kihara, Y; López-Rodríguez, ML; López-Vales, R; Martínez, RF; Mathivanan, S; Ortega-Gutiérrez, S; Puigdomenech, M; Rivera, R; Rodríguez de Fonseca, F; Sanchez-Martinez, M; Vázquez-Villa, H; Zambrana-Infantes, E; Zian, D | 1 |
| Casale, R | 1 |
| Eerdekens, M; Kandaswamy, P; Viel, E | 1 |
| Arora, V; Asgar, J; Chung, MK; Kumari, S; Li, T; Wang, S | 1 |
| Goto, S; Haji, A; Kodama, D; Miyazawa, K; Ohi, Y; Tamada, M | 1 |
| Ausín-Crespo, MD; de la Beldad-Diez, ML; Martín-de Castro, E; Roldán-Cuartero, J; Salcedo-Gámez, MÁ; Tong, H | 1 |
| Leavell, Y; Simpson, DM | 1 |
| Anders, B; Anders, M; Behrens, F; Fricker, L; Köhm, M; Kreuzer, M; Maier, C; Walter, C; Wolters, M; Zinn, S | 1 |
| Argôlo, IPR; Parisi, JR; Silva, JRTD; Silva, MLD | 1 |
| Assuncao, JP; Cardoso, C; de Castro, AM; Loureiro, MDC; Pinto, J; Vieira, IF | 1 |
| Beal, C; Braun, S; Brown, N; Connolly, B; Dicks, M; Erickson, J; Hayes, C; Helmonds, B; Kirkman, B; Koek, W; Lukose, E; Nagpal, AS; Nguyen, C; Nguyen, G; Olusanya, A; Peace, W; Rose, E; Trbovich, M; Yearsley, A | 1 |
| Baron, R; Dunst, A; Forstenpointner, J; Hüllemann, P; Sendel, M | 1 |
| Basbaum, AI; Braz, JM; Julius, D; Yuan, L; Yue, WWS | 1 |
| Curatolo, M | 1 |
| Cobos, EJ; Egea, J; Entrena, JM; García, AG; López, MG; Maroto, M; Montell, E; Padín, JF; Vergés, J | 1 |
| Basilicata, M; Bollero, P; Catalfamo, LM; De Ponte, FS; De Rinaldis, D; Della-Morte, D; Di Daniele, F; Di Daniele, N; Marrone, G; Noce, A; Paolino, V; Quattrone, D; Vivarini, I | 1 |
| Fuseya, S; Ishida, K; Ishida, T; Ito, M; Kawamata, M; Sakamoto, A; Tanaka, S | 1 |
| Allouchery, M; Géniaux, H; Miremont, G; Perino, J; Salvo, F; Trin, K | 1 |
| Boden, A; Bourgouin, M; Caunes-Hilary, N; Fabre, A; Filleron, T; Lodin, S; Lusque, A; Mauries, V; Moreau, C; Mounier, M; Poublanc, M | 1 |
| Jo, HJ; Kim, YH; Park, CK; Rahman, MM | 1 |
| Almeshal, D; Fontaine, R; Hans, GH; Investigators Team, TP; Roelant, E; Smits, E; Van Boxem, K; Vanlommel, L; Verhaegen, I | 1 |
| Ishida, S; Kikuchi, K; Murata, M; Tagawa, Y | 1 |
| Al-Shebab, U; Averell, N; Chiplunkar, M; Coombs, K; Goodwin, B; Janora, D; Salerno, R; Sannoh, U; Shah, V | 1 |
| Jang, HN; Oh, TJ | 1 |
| Alvarez-Leite, JI; Santos, EA; Silva, JL | 1 |
| Kaisler, M; Kumowski, N; Maier, C; Meyer-Frießem, CH; Schwarzer, A | 1 |
| Lucchini, C; Pickering, G | 1 |
| Gerstberger, R; Leisengang, S; Murgott, J; Nürnberger, F; Ott, D; Roth, J; Rummel, C; Schmidt, M | 1 |
| Cohrs, J; Kerns, R | 1 |
| Gestosa, SVS; Lares, AMG; Mulenas, NME; Ruivo, EFM | 1 |
| Antunes, FTT; Caminski, ES; Dallegrave, E; de Freitas, LM; de Souza, AH; Gomez, MV; Junior, CADS; Pereira, EMR | 1 |
| Bonezzi, C; Costantini, A; Cruccu, G; Dickenson, AH; Fornasari, DMM; Guardamagna, V; Palmieri, V; Polati, E; Zini, P | 1 |
| Bredthauer, A; Klier, TW; Lassen, CL; Meyer, K | 1 |
| Broussard, A; Carroll Turpin, MA; Cornett, EM; Ellis, S; Hall, OM; Kaye, AD; Lim, VM; Range, T | 1 |
| Cios, A; Filipek, B; Hubicka, U; Kubacka, M; Kwiecień, A; Marona, H; Pociecha, K; Rapacz, A; Sałat, K; Waszkielewicz, AM; Wyska, E; Żuromska-Witek, B | 1 |
| González-Anduaga, GM; López-Ortíz, M; Navarrete, A; Palomino-Hernández, O; Quiñonez-Bastidas, GN; Regla, I; Rocha-González, HI | 1 |
| Barbosa, P; Gomes, A; Goncalves, D; Rebelo, V | 1 |
| Coimbra, NC; de Freitas, RL; Elias-Filho, DH; Medeiros, AC; Medeiros, P; Negrini-Ferrari, SE; Oliveira-Silva, M | 1 |
| Barkai, O; Binshtok, AM; Butterman, R; Katz, B; Lev, S | 1 |
| Arora, V; Campbell, JN; Chung, MK | 1 |
| Alam, MS; He, X; Shen, B; Singla, RK; Sultana, A; Sun, Y | 1 |
| Abrams, RMC; Pedowitz, EJ; Simpson, DM | 1 |
| Araujo, BV; Barreto, F; Contri, RV; Costa, TD; de Miranda, ALP; Guterres, SS; Lima, CKF; Lorenzoni, R; Pohlmann, AR | 1 |
| Campbell, JN; Chung, MK; Connolly, J; Hanson, P; Lascelles, BDX; Meske, DS; Stevens, R | 1 |
| Anderson, T; Dodick, DW; Kopruszinski, CM; Navratilova, E; Porreca, F; Schwedt, TJ; Swiokla, J; Turnes, JM; Weinstein, TJ | 1 |
| Lin, CL; Lu, CC; Lu, YY; Tsai, HP; Wu, CH; Wu, MK | 1 |
| Brix Finnerup, N; Caspani, O; Garcia-Larrea, L; Ho, I; Kostenko, A; Leone, C; Mouraux, A; Nochi, Z; Pickering, G; Quesada, C; Stouffs, A; Tracey, I; Treede, RD; Truini, A; Wittayer, M | 1 |
| Hara, K; Haranishi, Y; Terada, T | 1 |
| Economou, S; Samara, E; Stamatiou, K; Tzimas, P | 1 |
| Argoff, C; Eerdekens, M; Engelen, S; Freynhagen, R; Perrot, S | 1 |
| Anand, P; Privitera, R | 1 |
| Das, B; McCrory, C; Mullins, CF; Rooney, A; Walsh, S | 1 |
| Acedo, G; Anido, J; Becerra, A; Bravo, E; Funcia, I; Rojo, E | 1 |
| Bioy, A; Cretineau, N; Etienne, R; Henry, A; Laurent, M; Salleron, J; Schohn, CH | 1 |
| Dorsey, SG; Greenspan, JD; Keaser, ML; Liu, Y; Meeker, TJ; Schmid, AC; Seminowicz, DA | 1 |
| Misery, L; Orliaguet, M | 1 |
| Bai, L; Chen, H; Chen, Z; Liu, Z; Niu, X; Sun, C; Tian, J; Wang, S; Wang, X; Zhang, M | 1 |
| Casals-Diaz, L; Dolly, O; Edupuganti, OP; Meng, J; Moriarty, O; Nealon, J; Wang, J; Zurawski, T | 1 |
| Charokopou, M; Pantiri, K; Stoker, M; Treur, M; van Nooten, F | 1 |
| Abe, K; Chiba, T; Kanbe, T; Oka, Y; Sashida, H; Taguchi, K; Utsunomiya, I | 1 |
| Berni, E; Calvo, JI; Currie, CJ; Ernault, E; Mankowski, C; Odeyemi, I; Plastira, C; Poole, CD; Thomas, R; Treadwell, C; Zafeiropoulou, E | 1 |
| Baron, R; Birklein, F; Cegla, T; Freynhagen, R; Heskamp, ML; Kern, KU; Maier, C; Maihöfner, C; Rolke, R; Seddigh, S; Sommer, C; Ständer, S; Treede, RD | 1 |
| Birklein, F; Breimhorst, M; Diener, SA; Drummond, PD; Geber, C; Krämer, HH; Vogt, T | 1 |
| Paisley, P; Serpell, M | 1 |
| Aldington, D; Bell, RF; Derry, S; Gaskell, H; Kalso, EA; Moore, RA; Phillips, T; Wiffen, PJ | 1 |
| Borges, MH; Cordeiro, MN; de Castro Junior, CJ; de Oliveira Adamante, G; De Prá, SD; de Souza, AH; Ferreira, J; Gomez, MV; Milioli, AM; Rigo, FK; Santa Cecilia, FV; Silva, JF; Trevisan, G | 1 |
| Filipczak-Bryniarska, I; Grodzicki, T; Kazior, L; Kleja, J; Krzemieniecki, K; Krzyzewski, RM; Kucharz, J; Michalowska-Kaczmarczyk, A; Strzepek, K; Wordliczek, J; Woron, J | 1 |
| Attal, N; Ernault, E; Gálvez, R; Maihöfner, C; Moyle, G; Navez, ML; Nurmikko, TJ; Stoker, M | 1 |
| Delorme, C; Martin, E; Mick, G; Pickering, G; Tiberghien, F | 1 |
| Cruccu, G; Ernault, E; Haanpää, M; McBride, WT; Nurmikko, TJ; Riaz, FK | 1 |
| Bardo-Brouard, P; Colin, A; Do, B; Goujon, C; Luizard, C; Paul, M; Valeyrie-Allanore, L; Wolkenstein, P | 1 |
| Hansson, P; Jensen, TS; Kvarstein, G; Strömberg, M | 1 |
| Crawford, P; Xu, Y | 1 |
| Baron, R; Binder, A; Enax-Krumova, EK; Geisslinger, G; Gierthmühlen, J; Henrich, F; Hüllemann, P; Klein, T; Lötsch, J; Magerl, W; Maier, C; Oertel, B; Schuh-Hofer, S; Tölle, TR; Treede, RD; Vollert, J | 1 |
| Fernandes, HL; Gama, R; Loureiro, MC; Pereira, FC; Tenreiro Pinto, J | 1 |
| Jäger-Becker, D | 1 |
| Jee, IG; Jung, KT; Lim, KJ; Oh, SH; Yoon, MH; Yu, BS | 1 |
| Aboud, M; Comai, S; De Gregorio, D; Enns, J; Gobbi, G; Lopez-Canul, M; Maione, S; McLaughlin, RJ; Ochoa-Sanchez, R; Posa, L | 1 |
| Blair, HA | 1 |
| Adamante, G; Bellinaso, F; Camponogara, C; Casoti, R; Coelho, YO; da Silva Silveira, E; de Almeida, AS; De Prá, SD; Desideri, AV; Ferreira, J; Milioli, AM; Oliveira, SM; Rigo, FK; Santos, MFC; Trevisan, G | 1 |
| Adamek, P; Heles, M; Palecek, J | 1 |
| Chomjit, A; Kulkantrakorn, K; Napunnaphat, P; Sithinamsuwan, P; Suwankanoknark, J; Tharavanij, T | 1 |
| Lantéri-Minet, M; Perrot, S | 2 |
| Arribas-Blázquez, M; Artalejo, AR; Barahona, MV; Ferrer-Montiel, A; Gualix, J; Jiménez, E; McIntosh, JM; Miras-Portugal, MT; Olivos-Oré, LA; Sánchez de la Muela, M; Solar, V | 1 |
| Lötsch, J; Weyer-Menkhoff, I | 1 |
| Arendt, G; Baron, R; Birklein, F; Cegla, T; Freynhagen, R; Gockel, HH; Heskamp, ML; Husstedt, IW; Jager, H; Joppich, R; Kern, KU; Leffler, A; Maier, C; Nagelein, HH; Rolke, R; Seddigh, S; Sommer, C; Stander, S; Treede, RD; Wagner, T; Wasner, G | 1 |
| Brown, S; Simpson, DM; Tobias, JK; Vanhove, GF | 1 |
| Cole, P; Derry, S; Moore, RA; Sven-Rice, A; Tan, T | 1 |
| Buijs, M; Gentgall, M; Hutchinson, MR; Kwok, YH; Rolan, P; Tuke, J; Williams, D | 1 |
| Heskamp, ML; Maihofner, C | 1 |
| Barros, AG; Castro-Junior, CJ; Cordeiro, MN; Dalmolin, G; Ferreira, J; Gomez, MV; Gomez, RS; Kushmerick, C; Milano, J; Richardson, M; Rigo, FK; Silva, JF; Silva, MA; Souza, AH | 1 |
| Dahan, A; Krebs-Brown, A; Martini, CH; Olofsen, E; Passier, P; Stoker, M; Yassen, A | 1 |
| Katz, NP; Mou, J; Paillard, F; Stoker, M; Trudeau, J; Turnbull, B | 1 |
| Poole, C; Roth-Daniek, A; Wagner, T | 1 |
| Gu, JG; Ling, JX; Xu, GY; Zuo, X | 1 |
| Heir, GM; Khan, J; Nasri-Heir, C | 1 |
| Besson, M; Sprenger, T; Suter, MR; Taub, E | 1 |
| Keavney, J; Murphy, K; O'Brien, J; Pollard, V; Weekes, G | 1 |
| Heskamp, ML; Maihöfner, CG | 1 |
| Baron, R; Helfert, S; Heskamp, ML; Höper, J; Maihöfner, CG | 1 |
| Kern, KU; Nowack, W; Poole, C | 1 |
| Fan, L; Guan, X; Hoffman, PN; Li, M; Tao, YX; Tiwari, V; Wang, W; Zhang, H; Zhao, JY | 1 |
| Anger, WH | 1 |
| Galluzzi, KE; Stanos, SP | 1 |
| Chichorro, JG; Cruz, LS; Kopruszinski, CM | 1 |
| Ernault, E; Fricová, J; Høye, K; Jensen, TS; Marques, S; Siciliano, T; Vanelderen, P | 1 |
| Baron, R; Helfert, SM; Reimer, M | 1 |
| Ganev, EG; Hiruma-Lima, CA; Martins, DF; Mazzardo-Martins, L; Nishijima, CM; Rocha, LR; Santos, AR | 1 |
| Al-Khrasani, M; Fürst, S; Khalefa, BI; Mousa, SA; Schäfer, M; Shakibaei, M; Shaqura, M; Zöllner, C | 1 |
| Amaral, LS; Barreiro, EJ; Fraga, CA; Guimaraes, MZ; Lacerda, RB; Lima, CK; Miranda, AL; Quintas, LE; Santos, BL; Silva, RM; Silva, RV | 1 |
| Pasvankas, G; Schumacher, M | 1 |
| Brooks, JR; Smith, H | 1 |
| Jakubowska, A; Kulig, K; Sałat, K | 1 |
| Gaul, C; Resch, S | 1 |
| Benedetti, F; Finnerup, NB; Grosen, K; Jensen, TS; Petersen, GL; Pilegaard, HK; Price, DD; Tracey, I; Vase, L | 1 |
| Baron, R; Gierthmühlen, J; Jansen, O; Rempe, T; Riedel, C; Stroman, PW; Wolff, S | 1 |
| Calabek, B; Callaghan, B; Feldman, EL | 1 |
| Grüneberg-Oelker, U; Husstedt, IW; Philipp, K; Raber, JM; Reichelt, D; Stubbe-Dräger, B | 1 |
| Finnerup, NB; Haroutounian, S; Jensen, TS; Nikolajsen, L | 1 |
| Donahue, RR; Grace, PM; Griggs, RB; Morgenweck, J; Sutton, A; Taylor, BK; Watkins, LR | 1 |
| Abusueva, BA; Evzelman, MA; Kamchatnov, PR; Volkov, AI | 1 |
| Dimova, V; Geisslinger, G; Hermens, H; Lötsch, J; Oertel, BG; Ultsch, A; Zimmermann, M | 1 |
| Filipek, B; Sałat, K | 1 |
| Baron, R; Enax-Krumova, EK; Maier, C; Mainka, T; Malewicz, NM; Treede, RD | 1 |
| Trbovich, M; Yang, H | 1 |
| Dimova, V; Hermens, H; Kabakci, G; Lautenbacher, S; Lötsch, J; Oertel, BG; Ultsch, A; Zimmermann, M | 1 |
| Bonezzi, C; Buonocore, M; Demartini, L | 1 |
| Dimova, V; Lötsch, J; Oertel, BG | 1 |
| Bang, S; Berta, T; Ji, RR; Kim, YH; Oh, SB; Wang, F; Xu, ZZ; Zhang, Y | 1 |
| Erlandson, M; Legerski, P; Onysko, M; Potthoff, J | 1 |
| Belmonte, C; de la Peña, E; Ferrer-Montiel, A; Gomis, A | 1 |
| Abdulahad, AK; Bosilkov, A; Chambers, C; Cruccu, G; Docu Axelarad, A; Ernault, E; Haanpää, M; McBride, WT; Nurmikko, TJ | 1 |
| Kern, KU; Weiser, T | 1 |
| Davletov, B; Ferrari, E; Geranton, SM; Hunt, SP; Leese, C; Maiarú, M; Mangione, AS; Obara, I; Tassorelli, C | 1 |
| Allen, R; Brady, KL; Campbell, CM; Campbell, JN; Diamond, E; Houghton, W; Kelly, M; Schmidt, WK | 1 |
| Chen, HS; Li, W; Li, XQ; Liu, BJ; Lu, Y; Wang, JX; Zhou, ZH | 1 |
| Matsuoka, H; Obata, H; Saito, S; Suto, T | 1 |
| Baron, R; Binder, A; Dierschke, R; Förster, M; Großkopf, M; Helfert, S; Hüllemann, P; Keller, T | 1 |
| Pereira, D; Rainho, C; Sequeira, J | 1 |
| Camponogara, C; Casoti, R; Chipindo, OJ; de Oliveira, SM; De Prá, SD; Ferreira, J; Ferro, PR; Manfron, MP; Milioli, AM; Rigo, FK; Trevisan, G | 1 |
| Coderre, TJ; Ding, S; Gyawali, S; Laferrière, A; Mahboubi, H; Mickeviciute, A; Nasir, H; Ragavendran, JV; Stochaj, U | 1 |
| Berta, T; Bey, AL; Chang, W; Han, Q; Ji, RR; Jiang, YH; Kim, YH; Lay, M; Liu, D; Wang, X; Zhang, Y; Zhang, ZJ | 1 |
| Jacobs, H; Katz, N; Long, SK; Ortega, E; Pazdera, L; Perrot, S; Snijder, RJ; Stoker, M; van der Stoep, M; Vinik, AI; Vinik, EJ | 1 |
| Cole, P; Derry, S; Moore, RA; Rice, AS; Tan, T | 1 |
| Choi, E; Kim, YC; Lee, PB; Lee, SC; Moon, JY; Nahm, FS | 1 |
| Aitken, E; Kingsmore, D; McColl, G | 1 |
| Engel, S; Lee, BB; McLachlan, E; Wasner, G | 1 |
| Adler, JE; Skoff, AM; Zhao, C | 1 |
| Noto, C; Pappagallo, M; Szallasi, A | 1 |
| Derry, S; Lloyd, R; McQuay, HJ; Moore, RA | 1 |
| Baron, R; Mahn, F | 1 |
| Aoki, T; Kakimoto, S; Kiso, T; Kohara, A; Kuramochi, T; Matsuoka, N; Tsuji, N; Watabiki, T; Yonezawa, K | 1 |
| Hishida, R; Komagata, S; Shibuki, K; Takeshita, N; Tamaki, K | 1 |
| Kobesova, A; Kolar, P; Kozak, J; Steindler, J; Vrba, I | 1 |
| Aoki, T; Kiso, T; Matsuoka, N; Tsukamoto, M; Watabiki, T | 1 |
| Chen, Y; Wang, ZJ; Yang, C | 1 |
| Draxler, J; Gustorff, B; Hauer, D; Seis, A; Thaler, J | 1 |
| Brenchat, A; Hamon, M; Romero, L; Vela, JM; Zamanillo, D | 1 |
| Holstege, JC; Hossaini, M; Jongen, JL; Saraç, C | 1 |
| Akasaka, Y; Hatta, A; Inoue, H; Sakai, A; Suzuki, H; Takasu, K; Tsukahara, M | 1 |
| Brew, BJ; Brown, S; Clifford, DB; Conway, B; Moyle, G; Simpson, DM; Tobias, JK; Vanhove, GF | 1 |
| Benedetti, M; Cadetti, F; dos Santos, P; Kusuda, R; Lucas, G; Merino, R; Ravanelli, MI; Zanon, S | 1 |
| Dyhr, H; Erichsen, HK; Hansen, MK; Marcher, L; Munro, G; Sheykhzade, M; Storm, A | 1 |
| Atsumi, E; Ishida, H; Kato, Y; Kodaira, H; Nakasato, Y; Saku, O; Shirakura, S; Sugimoto, Y | 1 |
| Baeyens, JM; Bura, A; Burgueño, J; Codony, X; Dordal, A; Encina, G; Escriche, M; Giraldo, J; Hernández, E; Laloya, M; López-García, JA; Maldonado, R; Merlos, M; Montero, A; Muro, A; Nadal, X; Plata-Salamán, CR; Portillo-Salido, E; Rivera-Arconada, I; Romero, L; Sánchez-Arroyos, R; Segalés, C; Vela, JM; Zamanillo, D | 1 |
| Amelink, GJ; Keppel Hesselink, JM; Kopsky, DJ | 1 |
| Comelli, F; Costa, B; D'Agostino, B; de Novellis, V; De Petrocellis, L; Di Marzo, V; Gatta, L; Guida, F; Luongo, L; Maione, S; Matteis, M; Sullo, N | 1 |
| Carlton, SM; Chung, JM; Chung, K; Li, B; Shi, Y; Tang, SJ; Wang, J; Yuan, S | 1 |
| Cheng, J; Fox, LE; Shen, J | 1 |
| Ikeda, R; Kato, F; Nagase, M; Nakao, A; Takahashi, Y | 1 |
| Malmierca, E; Martin, YB; Nuñez, A | 1 |
| Groninger, H; Schisler, RE | 1 |
| Bahrenberg, G; Bhondwe, RS; Blumberg, PM; Cho, SH; Choi, S; Christoph, T; DeAndrea-Lazarus, IA; Frank, R; Kang, DW; Kim, HS; Kim, MS; Kim, MY; Kim, YS; Kögel, BY; Kwak, EJ; Lee, J; Park, SG; Park, YS; Pearce, LV; Ryu, H; Schiene, K; Seo, S; Son, K; Stockhausen, H | 1 |
| Binshtok, AM; Hitomi, S; Iwata, K; Kitagawa, J; Lev, S; Maeda, T; Mostafeezur, RM; Seo, K; Suzuki, A; Suzuki, I; Yamada, Y; Yamamura, K; Zakir, HM | 1 |
| Derry, S; Moore, RA | 1 |
| Haanpää, M; Treede, RD | 1 |
| Kiss, G | 1 |
| Duan, B; Lou, S; Lowell, BB; Ma, Q; Vong, L | 1 |
| Chapman, V; Kelly, S | 1 |
| Liu, XJ; Sawynok, J; White, TD | 1 |
| Ahmad, M; Goucke, CR | 1 |
| Bach, FW; Gottrup, H; Jensen, TS; Kristensen, AD | 1 |
| Ueda, H | 1 |
| Closs, SP; Morgan, S; Perkins, P | 1 |
| Gardell, LR; Gardell, SE; Lai, J; Ossipov, MH; Porreca, F; Vanderah, TW; Wang, R | 1 |
| Derry, S; Edwards, JE; Mason, L; McQuay, HJ; Moore, RA | 1 |
| Clapp, DW; Hingtgen, CM; Roy, SL | 1 |
| Arendt-Nielsen, L; Chen, HS; He, X; Wang, Y; Wen, WW; You, HJ | 1 |
| Capone, JG; Eleopra, R; Gastaldo, E; Geppetti, P; Quatrale, R; Sensi, M; Tola, MR; Tugnoli, V | 1 |
| Briggs, MA; Bruton, G; Calver, AR; Chessell, I; Crook, B; Davis, JB; Davis, RP; Foley, AG; Heslop, T; Hirst, WD; Medhurst, AD; Medhurst, SJ; Ociepka, S; Orlek, B; Ray, A; Regan, CM; Sargent, B; Schogger, J; Stean, TO; Trail, BK; Upton, N; White, T; Wilson, DM | 1 |
| Finnerup, NB; Jensen, TS; Johannesen, IL; Pedersen, LH; Terkelsen, AJ | 1 |
| Benes, PS; Sandford, PR | 1 |
| Remadevi, R; Szallisi, A | 1 |
| Hwang, SJ; Kim, E; Kim, J; Kim, SM; Lee, SE; Shin, HK | 1 |
| Koltzenburg, M; Torebjörk, HE | 1 |
| Sokołowski, P | 1 |
| Watson, CP | 1 |
| Bryson, HM; Rains, C | 1 |
| Dyck, PJ; Litchy, WJ; Low, PA; O'Brien, PC; Opfer-Gehrking, TL | 1 |
| Gibson, SJ; Helme, RD; Morris, GC | 1 |
| Kost, RG; Straus, SE | 1 |
| Bromm, B; Darsow, U; Lorenz, J; Ring, J | 1 |
| Baumann, TK; Burchiel, KJ; Ingram, SL; Martenson, ME | 1 |
| Gilhar, A; Markovits, E | 1 |
| Brown, SI; Feldman, ST; Frucht-Pery, J | 1 |
| Cascino, TL; Dhaliwal, HS; Ellison, N; Ghosh, C; Hatfield, AK; Kugler, J; Loprinzi, CL; Miser, A; Molina, R; Rowland, KM; Sloan, JA; Vukov, AM; Wender, DB | 1 |
| Chasuk, R | 1 |
| Mansikka, H; Pertovaara, A | 1 |
| Büchel, C; Diener, CH; Eichten, C; Jüptner, M; Kaube, H; May, A; Rijntjes, M; Weiller, C | 1 |
| Bennett, GJ; Berman, KF; Byas-Smith, MG; Gracely, RH; Iadarola, MJ; Max, MB; Zeffiro, TA | 1 |
| Fuchs, PN; Meyer, RA; Pappagallo, M | 1 |
| Beydoun, A | 1 |
| Bramwell, S; Field, MJ; Hughes, J; Singh, L | 1 |
| Clark, GT; Merrill, RL; Padilla, M | 1 |
| Brennum, J; Fields, HL; Petersen, KL; Rowbotham, MC; Sandroni, P | 1 |
| Leok, GC; Sugeng, MW; Yosipovitch, G | 1 |
| Kashiba, H; Senba, E | 1 |
| Chung, JM; Kim, HT; Lee, DH; Lee, SE; Park, SK | 1 |
| Arendt-Nielsen, L; Gjedde, A; Jensen, TS; Kupers, RC; Svensson, P; Witting, N | 1 |
| Baumgärtner, U; Hopf, HC; Klein, T; Magerl, W; Treede, RD | 1 |
| Ollat, H | 1 |
| Rowbotham, MC | 1 |
| Koehler, PJ | 1 |
| Arroyo, JF | 1 |
| Carmichael, JK | 1 |
| Hentrich, M; Ochs, G; Peikert, A | 1 |
| Arendt-Nielsen, L; Bjerring, P; Søderberg, U | 1 |
| Gibson, SJ; Helme, RD; LeVasseur, SA | 1 |
| van Horssen, N | 1 |
| Bernstein, JE | 2 |
| Hawk, RJ; Millikan, LE | 1 |
| Evans, RJ; Watson, PNC; Watt, VR | 1 |
| Ross, DR; Varipapa, RJ | 1 |
| Bernstein, JE; Bickers, DR; Dahl, MV; Korman, NJ; Millikan, LE | 1 |
| Bucci, FA; Gabriels, CF; Krohel, GB | 1 |
| Carter, BE; Delaney, C; Kotzmann, RR; Roberts, RG; Westerman, DA; Westerman, RA; Widdop, RE | 1 |
| Sugar, SJ | 1 |
| Don, PC | 1 |
| Bernstein, JE; Bickers, DR; Dahl, MV; Roshal, JY | 1 |
56 review(s) available for capsaicin and Neuralgia
| Article | Year |
|---|---|
Capsaicin 179-mg cutaneous patch in the treatment of post-surgical neuropathic pain: a scoping review of current evidence and place in therapy.
Topics: Adult; Capsaicin; Diabetic Neuropathies; Humans; Neuralgia; Neuralgia, Postherpetic; Pain, Postoperative; Transdermal Patch | 2021 |
The role of the capsaicin 8% patch in the treatment of painful diabetic peripheral neuropathy.
Topics: Capsaicin; Diabetes Mellitus; Diabetic Neuropathies; Humans; Neuralgia; Pain Management | 2022 |
The Utility of
Topics: Capsaicin; Capsicum; Dentistry; Humans; Neuralgia; Plant Extracts | 2022 |
Topical capsaicin for the management of painful diabetic neuropathy: a narrative systematic review.
Topics: Capsaicin; Diabetes Mellitus; Diabetic Neuropathies; Humans; Neuralgia | 2023 |
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy.
Topics: Capsaicin; Diabetes Mellitus; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neuralgia; Quality of Life; United States | 2023 |
Are We Ready to Recommend Capsaicin for Disorders Other Than Neuropathic Pain?
Topics: Capsaicin; Capsicum; Neuralgia; Obesity | 2023 |
Topical Treatment of Localized Neuropathic Pain in the Elderly.
Topics: Administration, Topical; Aged; Aged, 80 and over; Analgesics; Capsaicin; Humans; Lidocaine; Middle Aged; Neuralgia | 2020 |
Capsaicin 8% dermal patch in clinical practice: an expert opinion.
Topics: Administration, Topical; Analgesics; Capsaicin; Cost-Benefit Analysis; Expert Testimony; Humans; Neuralgia; Pregabalin; Quality of Life; Transdermal Patch; TRPV Cation Channels | 2020 |
Novel Agents in Neuropathic Pain, the Role of Capsaicin: Pharmacology, Efficacy, Side Effects, Different Preparations.
Topics: Analgesics; Capsaicin; Drug-Related Side Effects and Adverse Reactions; Humans; Migraine Disorders; Neuralgia; Treatment Outcome | 2020 |
Fight fire with fire: Neurobiology of capsaicin-induced analgesia for chronic pain.
Topics: Analgesia; Analgesics; Animals; Calpain; Capsaicin; Chronic Pain; Mice; Neuralgia; TRPV Cation Channels | 2021 |
Topical Capsaicin for the Treatment of Neuropathic Pain.
Topics: Administration, Cutaneous; Analgesics; Animals; Capsaicin; Disease Models, Animal; Humans; Neuralgia; Sensory Receptor Cells; Treatment Outcome; TRPV Cation Channels | 2021 |
A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults.
Topics: Adult; Capsaicin; Diabetes Mellitus; Diabetic Neuropathies; Humans; Neuralgia; Pain Management; Quality of Life | 2021 |
Injectable Capsaicin for the Management of Pain Due to Osteoarthritis.
Topics: Animals; Capsaicin; Humans; Neuralgia; Nociceptors; Osteoarthritis; TRPV Cation Channels | 2021 |
Human surrogate models of central sensitization: A critical review and practical guide.
Topics: Animals; Capsaicin; Central Nervous System Sensitization; Humans; Hyperalgesia; Neuralgia; Pain Measurement | 2021 |
Capsaicin 8% patch Qutenza and other current treatments for neuropathic pain in chemotherapy-induced peripheral neuropathy (CIPN).
Topics: Administration, Topical; Antineoplastic Agents; Capsaicin; Humans; Neuralgia; Pain Management | 2021 |
Neuropathic and Psychogenic Components of Burning Mouth Syndrome: A Systematic Review.
Topics: Burning Mouth Syndrome; Capsaicin; Cytokines; Humans; Low-Level Light Therapy; Neuralgia; Pain; Pain Measurement; Pain Threshold; Perception; Physical Stimulation; Sensory Thresholds; Surveys and Questionnaires; Thioctic Acid | 2021 |
Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
Topics: Administration, Oral; Analgesics; Capsaicin; Diabetic Neuropathies; Humans; Neuralgia; Transdermal Patch | 2017 |
The role of topiceuticals in cancer pain.
Topics: Administration, Cutaneous; Analgesics, Opioid; Anesthetics, Local; Cancer Pain; Capsaicin; Clinical Trials as Topic; Clonidine; Drug Therapy, Combination; Humans; Lidocaine; Menthol; Neuralgia; Pain Management; Pain Measurement | 2017 |
Topical analgesics for acute and chronic pain in adults - an overview of Cochrane Reviews.
Topics: Acute Pain; Adult; Analgesics; Arthritis, Rheumatoid; Capsaicin; Chronic Pain; Diclofenac; Humans; Ketoprofen; Musculoskeletal Pain; Neuralgia; Numbers Needed To Treat; Osteoarthritis; Piroxicam; Publication Bias; Review Literature as Topic | 2017 |
Localized neuropathic pain: an expert consensus on local treatments.
Topics: Administration, Topical; Aged; Analgesics; Anesthetics, Local; Animals; Capsaicin; Humans; Lidocaine; Neuralgia; Quality of Life; Randomized Controlled Trials as Topic | 2017 |
Topical Capsaicin for Treatment of Chronic Neuropathic Pain in Adults.
Topics: Administration, Topical; Adult; Capsaicin; Chronic Pain; Evidence-Based Medicine; Humans; Neuralgia; Risk Assessment; Sensory System Agents | 2017 |
Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.
Topics: Administration, Cutaneous; Analgesics; Capsaicin; HIV Infections; Humans; Neuralgia; Neuralgia, Postherpetic; Pain Management; Pregabalin; Transdermal Patch; TRPV Cation Channels | 2018 |
Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain.
Topics: Adolescent; Adult; Capsaicin; Child; Child, Preschool; Female; Germany; Humans; Male; Middle Aged; Neuralgia; Pain Management; Practice Guidelines as Topic; Sensory System Agents; Time Factors; Transdermal Patch | 2013 |
Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Topics: Administration, Topical; Adult; Analgesics; Capsaicin; Chronic Disease; Diabetic Neuropathies; HIV Infections; Humans; Neuralgia; Neuralgia, Postherpetic; Ointments; Pain, Postoperative; Randomized Controlled Trials as Topic | 2013 |
Efficacy of Qutenza® (capsaicin) 8% patch for neuropathic pain: a meta-analysis of the Qutenza Clinical Trials Database.
Topics: Aged; Aged, 80 and over; Capsaicin; Clinical Trials as Topic; Databases, Factual; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Neuralgia; Sensory System Agents; Transdermal Patch | 2013 |
Topical medications as treatment of neuropathic orofacial pain.
Topics: Administration, Cutaneous; Capsaicin; Cyclooxygenase Inhibitors; Diclofenac; Facial Pain; Humans; Lidocaine; Neuralgia; Sensory System Agents; Voltage-Gated Sodium Channel Blockers | 2013 |
[New concepts in the pathophysiology, diagnosis and treatment of neuropathic pain].
Topics: Analgesics; Capsaicin; Clonidine; Diabetic Neuropathies; Headache; Humans; Neuralgia; Pain Measurement; Sensory System Agents; Treatment Outcome | 2013 |
Topical therapies in the management of chronic pain.
Topics: Administration, Cutaneous; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Chronic Pain; Diclofenac; Humans; Ibuprofen; Irritants; Ketoprofen; Lidocaine; Musculoskeletal Pain; Neoplasms; Neuralgia; Neuralgia, Postherpetic; Osteoarthritis, Knee; Palliative Care | 2013 |
Phenotyping neuropathic pain patients: implications for individual therapy and clinical trials.
Topics: Capsaicin; Clinical Trials as Topic; Humans; Neuralgia; Pain Management; Pain Measurement; Palliative Care; Retrospective Studies; Sensory System Agents; Treatment Outcome | 2014 |
Topical capsaicin formulations in the management of neuropathic pain.
Topics: Administration, Topical; Animals; Capsaicin; Chemistry, Pharmaceutical; Humans; Neuralgia; Neuralgia, Postherpetic; Nociceptors | 2014 |
Capsaicin-based therapies for pain control.
Topics: Animals; Capsaicin; Humans; Neuralgia; Nociception; Pain; TRPV Cation Channels | 2014 |
Zucapsaicin for the treatment of neuropathic pain.
Topics: Adult; Analgesics; Animals; Capsaicin; Headache; Humans; Neuralgia; Osteoarthritis, Knee; Pain; Severity of Illness Index | 2014 |
Therapy for diabetic neuropathy: an overview.
Topics: Analgesics, Opioid; Animals; Capsaicin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Neuralgia | 2014 |
[Capsaicin in treatment of neuropathic pain].
Topics: Animals; Capsaicin; Humans; Neuralgia; Sensory System Agents | 2014 |
Targeting neuropathic pain: consider these alternatives.
Topics: Acetylcarnitine; Capsaicin; Complementary Therapies; Family Practice; gamma-Linolenic Acid; Humans; Magnesium; Neuralgia; Peripheral Nervous System Diseases; Thioctic Acid; Vitamin B Complex | 2015 |
What role for capsaicin in diabetic peripheral neuropathy?
Topics: Administration, Cutaneous; Capsaicin; Diabetic Neuropathies; Disease Management; Humans; Neuralgia | 2016 |
Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Topics: Administration, Topical; Adult; Analgesics; Capsaicin; Chronic Pain; Diabetic Neuropathies; HIV Infections; Humans; Neuralgia; Neuralgia, Postherpetic; Numbers Needed To Treat; Ointments; Pain, Postoperative; Randomized Controlled Trials as Topic | 2017 |
Topical capsaicin for chronic neuropathic pain in adults.
Topics: Administration, Topical; Adult; Analgesics; Capsaicin; Chronic Disease; Diabetic Neuropathies; HIV Infections; Humans; Neuralgia; Neuralgia, Postherpetic; Ointments; Pain, Postoperative | 2009 |
Topical capsaicin for neuropathic pain #255.
Topics: Administration, Topical; Analgesics; Capsaicin; Humans; Neuralgia | 2012 |
Topical capsaicin (low concentration) for chronic neuropathic pain in adults.
Topics: Administration, Topical; Adult; Capsaicin; Chronic Pain; Drug Administration Schedule; Humans; Neuralgia; Randomized Controlled Trials as Topic; Sensory System Agents | 2012 |
Capsaicin for neuropathic pain: linking traditional medicine and molecular biology.
Topics: Analgesics; Animals; Capsaicin; Humans; Medicine, Traditional; Neuralgia; TRPV Cation Channels | 2012 |
Management strategies for the treatment of neuropathic pain in the elderly.
Topics: Aged; Analgesics, Opioid; Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Capsaicin; Cognitive Behavioral Therapy; Diabetic Neuropathies; Herpes Simplex; Humans; Lidocaine; Nerve Block; Nervous System Diseases; Neuralgia; Pain; Pain Management; Physical Therapy Modalities; Stroke; Tramadol | 2002 |
Systematic review of topical capsaicin for the treatment of chronic pain.
Topics: Administration, Topical; Analgesics; Capsaicin; Chronic Disease; Humans; Musculoskeletal Diseases; Neuralgia; Pain; Pain Measurement; Randomized Controlled Trials as Topic; Treatment Outcome | 2004 |
[Capsaicin in pain therapy].
Topics: Arthralgia; Capsaicin; Cluster Headache; Diabetic Neuropathies; Herpes Zoster; Humans; Neuralgia; Trigeminal Neuralgia | 1994 |
Topical capsaicin as an adjuvant analgesic.
Topics: Administration, Topical; Analgesics; Animals; Arthritis; Capsaicin; Clinical Trials as Topic; Diabetic Neuropathies; Humans; Mastectomy; Neuralgia; Pain, Postoperative | 1994 |
Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Capsaicin; Clinical Trials as Topic; Diabetic Neuropathies; Herpes Zoster; Humans; Middle Aged; Neuralgia; Osteoarthritis | 1995 |
Postherpetic neuralgia--pathogenesis, treatment, and prevention.
Topics: Antiviral Agents; Capsaicin; Central Nervous System Agents; Drug Therapy, Combination; Glucocorticoids; Herpes Zoster; Humans; Neuralgia | 1996 |
Capsaicin--an effective topical treatment in pain.
Topics: Administration, Cutaneous; Analgesics; Capsaicin; Chronic Disease; Diabetic Neuropathies; Herpes Simplex; Humans; Neuralgia; Pain; Rheumatic Diseases | 1997 |
Postherpetic neuralgia: role of gabapentin and other treatment modalities.
Topics: Acetates; Administration, Topical; Age Factors; Aged; Ambulatory Care; Amines; Analgesics; Anticonvulsants; Antidepressive Agents, Tricyclic; Capsaicin; Carbamazepine; Clinical Trials as Topic; Cross-Over Studies; Cyclohexanecarboxylic Acids; Double-Blind Method; Drug Administration Schedule; Female; Gabapentin; gamma-Aminobutyric Acid; Herpes Zoster; Humans; Male; Middle Aged; Narcotics; Neuralgia; Pain; Risk Factors; Severity of Illness Index; Treatment Outcome | 1999 |
Topical medications for orofacial neuropathic pain: a review.
Topics: Administration, Topical; Analgesics; Anesthetics, Local; Capsaicin; Cranial Nerve Diseases; Cranial Nerve Neoplasms; Drug Carriers; Drug Delivery Systems; Facial Pain; Humans; Neuralgia; Neuroma; Phosphatidylcholines | 2000 |
Post herpetic neuralgia and the dermatologist.
Topics: Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Herpesviridae Infections; Humans; Neuralgia; Skin; Skin Diseases | 2001 |
[Primary sensory neurons expressing histamine H1-receptor mRNA].
Topics: Animals; Capsaicin; Gene Expression; Histamine; Humans; Neuralgia; Neurons, Afferent; Neuropeptides; Receptors, Histamine H1; RNA, Messenger; Up-Regulation | 2001 |
[Pharmacological treatment of neuropathic pain].
Topics: Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Baclofen; Capsaicin; Chronic Disease; Diabetic Neuropathies; Humans; Narcotics; Neuralgia; Pain; Peripheral Nervous System Diseases | 1992 |
Treatment of postherpetic neuralgia.
Topics: Analgesia; Antidepressive Agents; Capsaicin; Herpes Zoster; Humans; Neuralgia | 1992 |
Treatment of herpes zoster and postherpetic neuralgia.
Topics: Acupuncture Therapy; Acyclovir; Amitriptyline; Anesthetics, Local; Anticonvulsants; Antipsychotic Agents; Capsaicin; Herpes Zoster; Humans; Neuralgia; Transcutaneous Electric Nerve Stimulation; Ultrasonic Therapy | 1991 |
Capsaicin in dermatologic disease.
Topics: Capsaicin; Humans; Middle Aged; Neuralgia; Pruritus; Skin Diseases; Substance P | 1988 |
43 trial(s) available for capsaicin and Neuralgia
| Article | Year |
|---|---|
Capsaicin 8% Patch for Spinal Cord Injury Focal Neuropathic Pain, a Randomized Controlled Trial.
Topics: Capsaicin; Humans; Neuralgia; Quality of Life; Single-Blind Method; Spinal Cord Injuries | 2023 |
Capsaicin treatment in neuropathic pain: axon reflex vasodilatation after 4 weeks correlates with pain reduction.
Topics: Axons; Capsaicin; Humans; Neuralgia; Nociceptors; Quality of Life; Reflex; Vasodilation | 2023 |
A randomized, double-blinded, placebo-controlled, crossover study of the HCN channel blocker ivabradine in a capsaicin-induced pain model in healthy volunteers.
Topics: Adult; Analgesics; Calcium Channel Blockers; Capsaicin; Cross-Over Studies; Female; Healthy Volunteers; Humans; Hyperalgesia; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Neuralgia; Nucleotides, Cyclic | 2022 |
Study protocol of the TEC-ORL clinical trial: a randomized comparative phase II trial investigating the analgesic activity of capsaicin vs Laroxyl in head and neck Cancer survivors presenting with neuropathic pain sequelae.
Topics: Amitriptyline; Analgesics; Capsaicin; Clinical Trials, Phase II as Topic; Head and Neck Neoplasms; Humans; Multicenter Studies as Topic; Neuralgia; Quality of Life; Randomized Controlled Trials as Topic; Survivors | 2022 |
Considerations on the Obstacles That Lead to Slow Recruitment in a Pain Management Clinical Trial: Experiences from the Belgian PELICAN (PrEgabalin Lidocaine Capsaicin Neuropathic Pain) Pragmatic Study.
Topics: Belgium; Capsaicin; Humans; Lidocaine; Neuralgia; Pain Management; Pilot Projects; Pregabalin; Quality of Life | 2023 |
Interest of a standardized hypnotic message for the reduction of pain and anxiety in cancer patients treated by capsaicin patch for neuropathic pain: a randomized controlled trial.
Topics: Administration, Topical; Adult; Aged; Analgesics; Anxiety; Capsaicin; Female; Humans; Hypnosis; Male; Middle Aged; Music Therapy; Neoplasms; Neuralgia; Pain, Procedural; Treatment Outcome | 2021 |
Interaction of acupuncture treatment and manipulation laterality modulated by the default mode network.
Topics: Adult; Anxiety; Brain; Capsaicin; Depression; Electroacupuncture; Female; Functional Laterality; Healthy Volunteers; Humans; Male; Models, Neurological; Musculoskeletal Manipulations; Neuralgia; Oxygen; Pain Measurement; Single-Blind Method; Treatment Outcome; Young Adult | 2017 |
Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
Topics: Adult; Analgesics; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Management; Pain Measurement; Quality of Life; Sensory System Agents; Transdermal Patch; Treatment Outcome | 2017 |
High-dose 8% capsaicin patch in treatment of chemotherapy-induced peripheral neuropathy: single-center experience.
Topics: Aged; Analgesics, Non-Narcotic; Antineoplastic Agents; Capsaicin; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neuralgia; Organoplatinum Compounds; Oxaliplatin; Transdermal Patch; Treatment Outcome | 2017 |
Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain: A 52-Week, Open-Label, Single-Arm, Safety Study.
Topics: Aged; Analgesics, Non-Narcotic; Capsaicin; Female; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Prospective Studies; Reflex; Sensation; Transdermal Patch; Treatment Outcome | 2017 |
Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Capsaicin; Female; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Pregabalin; Treatment Outcome; Young Adult | 2018 |
[In process].
Topics: Administration, Cutaneous; Capsaicin; Diabetic Neuropathies; Double-Blind Method; Humans; Neuralgia; Peripheral Nervous System Diseases | 2016 |
0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial.
Topics: Adult; Capsaicin; Cross-Over Studies; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuralgia; Pain Management; Sensory System Agents; Skin Cream | 2019 |
TRPA1 Sensitization Produces Hyperalgesia to Heat but not to Cold Stimuli in Human Volunteers.
Topics: Acrolein; Adult; Capsaicin; Cold Temperature; Cross-Over Studies; Female; Healthy Volunteers; Hot Temperature; Humans; Hyperalgesia; Male; Menthol; Neuralgia; Pain Threshold; TRPA1 Cation Channel; TRPM Cation Channels; TRPV Cation Channels; Young Adult | 2019 |
NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
Topics: Adult; Capsaicin; Double-Blind Method; Endpoint Determination; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neuralgia; Neurologic Examination; Pain Management; Pain Measurement; Patient Satisfaction; Peripheral Nervous System Diseases; Sensory Receptor Cells; Skin; Transdermal Patch; Treatment Outcome | 2014 |
Low-dose endotoxin potentiates capsaicin-induced pain in man: evidence for a pain neuroimmune connection.
Topics: Adult; Capsaicin; Cross-Over Studies; Double-Blind Method; Endotoxins; Humans; Hyperalgesia; Male; Neuralgia; Pain Measurement; Pain Threshold; Physical Stimulation; Toll-Like Receptor 4 | 2013 |
Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
Topics: Administration, Cutaneous; Analgesics; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Management; Peripheral Nervous System Diseases; Transdermal Patch; Treatment Outcome | 2013 |
A novel approach to identify responder subgroups and predictors of response to low- and high-dose capsaicin patches in postherpetic neuralgia.
Topics: Aged; Aged, 80 and over; Capsaicin; Chronic Pain; Double-Blind Method; Female; Humans; Lidocaine; Male; Middle Aged; Neuralgia; Neuralgia, Postherpetic; Transdermal Patch; Treatment Outcome | 2013 |
Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study.
Topics: Administration, Topical; Adult; Aged; Analgesics; Capsaicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Prospective Studies; Quality of Life; Treatment Outcome | 2014 |
High concentration capsaicin for treatment of peripheral neuropathic pain: effect on somatosensory symptoms and identification of treatment responders.
Topics: Adult; Aged; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Prospective Studies; Sensory System Agents; Somatosensory Disorders; Surveys and Questionnaires | 2014 |
Tolerability of the capsaicin 8% patch following pretreatment with lidocaine or tramadol in patients with peripheral neuropathic pain: a multicentre, randomized, assessor-blinded study.
Topics: Adult; Aged; Analgesics, Opioid; Anesthetics, Local; Capsaicin; Female; Humans; Lidocaine; Male; Middle Aged; Neuralgia; Pain Measurement; Premedication; Sensory System Agents; Single-Blind Method; Tramadol; Transdermal Patch; Treatment Outcome | 2014 |
Spinal fMRI reveals decreased descending inhibition during secondary mechanical hyperalgesia.
Topics: Adult; Capsaicin; Female; Hot Temperature; Humans; Hyperalgesia; Magnetic Resonance Imaging; Male; Neuralgia; Pontine Tegmentum; Radiography; Spinal Cord | 2014 |
Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain.
Topics: Adult; Aged; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Sensory System Agents; Transdermal Patch; Treatment Outcome | 2015 |
A more pessimistic life orientation is associated with experimental inducibility of a neuropathy-like pain pattern in healthy individuals.
Topics: Adolescent; Adult; Algorithms; Capsaicin; Cognition Disorders; Female; Healthy Volunteers; Humans; Male; Models, Theoretical; Mood Disorders; Neuralgia; Optimism; Pain Measurement; Principal Component Analysis; Sensory System Agents; Surveys and Questionnaires; Young Adult | 2015 |
Capsaicin 8% patch versus oral pregabalin in patients with peripheral neuropathic pain.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Management; Pain Measurement; Pregabalin; Transdermal Patch; Treatment Outcome; Young Adult | 2016 |
A randomized, double-blind, placebo-controlled trial of injected capsaicin for pain in Morton's neuroma.
Topics: Adult; Aged; Capsaicin; Double-Blind Method; Female; Humans; Male; Middle Aged; Morton Neuroma; Neuralgia; Treatment Outcome | 2016 |
Evaluation of the antihyperalgesic effect of tapentadol in two human evoked pain models - the TapCapMentho pilot trial.
Topics: Adult; Capsaicin; Cross-Over Studies; Double-Blind Method; Female; Humans; Hyperalgesia; Male; Neuralgia; Pain; Pain Measurement; Pain Threshold; Phenols; Pilot Projects; Tapentadol; Young Adult | 2016 |
Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.
Topics: Administration, Cutaneous; Adult; Aged; Capsaicin; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Neuralgia; Outcome Assessment, Health Care; Sensory System Agents; Standard of Care | 2016 |
Efficacy and Safety of 0.625% and 1.25% Capsaicin Patch in Peripheral Neuropathic Pain: Multi-Center, Randomized, and Semi-Double Blind Controlled Study.
Topics: Capsaicin; Double-Blind Method; Humans; Neuralgia; Pain Management; Pain Measurement; Transdermal Patch; Treatment Outcome | 2017 |
Antihyperalgesic efficacy of 5% lidocaine medicated plaster in capsaicin and sunburn pain models--two randomized, double-blinded, placebo-controlled crossover trials in healthy volunteers.
Topics: Administration, Cutaneous; Adult; Anesthetics, Local; Capsaicin; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hyperalgesia; Lidocaine; Neuralgia; Pain Measurement; Physical Stimulation; Sunburn; Treatment Outcome; Young Adult | 2011 |
A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy.
Topics: Administration, Cutaneous; Adult; Analgesics, Non-Narcotic; Antipruritics; Capsaicin; Double-Blind Method; Female; Foot Diseases; HIV Infections; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Polyneuropathies | 2012 |
Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin.
Topics: Adult; Botulinum Toxins, Type A; Capsaicin; Erythema; Female; Hot Temperature; Humans; Male; Middle Aged; Neuralgia; Neuromuscular Agents; Pain Threshold; Skin; Vasodilation | 2007 |
Reaction to topical capsaicin in spinal cord injury patients with and without central pain.
Topics: Administration, Topical; Adult; Aged; Analgesics, Non-Narcotic; Autonomic Nervous System; Capsaicin; Cold Temperature; Female; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Physical Stimulation; Spinal Cord Injuries; Thoracic Vertebrae | 2007 |
Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Capsaicin; Double-Blind Method; Female; Humans; Male; Middle Aged; Nerve Fibers; Neuralgia; Ointments; Peripheral Nervous System Diseases; Placebos; Sweat | 1995 |
Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients.
Topics: Administration, Topical; Aged; Capsaicin; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Neuralgia; Ointments; Pain Measurement; Pain, Postoperative | 1997 |
Experimental cranial pain elicited by capsaicin: a PET study.
Topics: Acute Disease; Adult; Analysis of Variance; Capsaicin; Cerebrovascular Circulation; Forehead; Humans; Injections, Subcutaneous; Male; Neuralgia; Reference Values; Tomography, Emission-Computed | 1998 |
Neural activation during acute capsaicin-evoked pain and allodynia assessed with PET.
Topics: Acute Disease; Adult; Capsaicin; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Humans; Image Processing, Computer-Assisted; Injections, Subcutaneous; Male; Middle Aged; Neuralgia; Perception; Stress, Mechanical; Tomography, Emission-Computed | 1998 |
Topical EMLA pre-treatment fails to decrease the pain induced by 1% topical capsaicin.
Topics: Administration, Topical; Adult; Anesthetics, Local; Capsaicin; Drug Tolerance; Female; Humans; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Middle Aged; Neuralgia; Pain Threshold; Prilocaine | 1999 |
Postherpetic neuralgia: role of gabapentin and other treatment modalities.
Topics: Acetates; Administration, Topical; Age Factors; Aged; Ambulatory Care; Amines; Analgesics; Anticonvulsants; Antidepressive Agents, Tricyclic; Capsaicin; Carbamazepine; Clinical Trials as Topic; Cross-Over Studies; Cyclohexanecarboxylic Acids; Double-Blind Method; Drug Administration Schedule; Female; Gabapentin; gamma-Aminobutyric Acid; Herpes Zoster; Humans; Male; Middle Aged; Narcotics; Neuralgia; Pain; Risk Factors; Severity of Illness Index; Treatment Outcome | 1999 |
Capsaicin evoked pain and allodynia in post-herpetic neuralgia.
Topics: Administration, Topical; Aged; Aged, 80 and over; Capsaicin; Female; Herpes Zoster; Humans; Immunohistochemistry; Male; Middle Aged; Neuralgia; Neurons, Afferent; Nociceptors; Pain; Skin | 2000 |
Experimental brush-evoked allodynia activates posterior parietal cortex.
Topics: Adult; Brain; Brain Mapping; Capsaicin; Dominance, Cerebral; Female; Humans; Male; Neuralgia; Pain Measurement; Pain Threshold; Physical Stimulation; Reference Values; Regional Blood Flow; Tomography, Emission-Computed | 2001 |
Topical 0.025% capsaicin in chronic post-herpetic neuralgia: efficacy, predictors of response and long-term course.
Topics: Administration, Cutaneous; Adult; Aged; Capsaicin; Drug Evaluation; Female; Follow-Up Studies; Herpes Zoster; Humans; Male; Middle Aged; Neuralgia; Pain | 1991 |
Topical capsaicin treatment of chronic postherpetic neuralgia.
Topics: Administration, Topical; Aged; Aged, 80 and over; Capsaicin; Double-Blind Method; Female; Herpes Zoster; Humans; Male; Middle Aged; Neuralgia | 1989 |
147 other study(ies) available for capsaicin and Neuralgia
| Article | Year |
|---|---|
Discovery of Nonpungent Transient Receptor Potential Vanilloid 1 (TRPV1) Agonist as Strong Topical Analgesic.
Topics: Analgesics; Animals; Capsaicin; CHO Cells; Cricetulus; Drug Discovery; Hyperalgesia; Mice, Inbred ICR; Neuralgia; Phenylurea Compounds; Swine; Thiazoles; TRPV Cation Channels | 2020 |
A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA
Topics: Analgesics; Animals; Cell Line; Cell Movement; Cells, Cultured; Drug Discovery; Female; Humans; Hydrocarbons, Aromatic; Mice, Inbred C57BL; Models, Molecular; Neuralgia; Pain Perception; Rats, Wistar; Receptors, Lysophosphatidic Acid; Sensory Receptor Cells | 2020 |
Treatment Impact on Patient-Reported Outcomes in Peripheral Neuropathic Pain: Comparing Single Intervention With Topical High-Concentration Capsaicin to Daily Oral Pregabalin.
Topics: Analgesics; Capsaicin; Humans; Neuralgia; Patient Reported Outcome Measures; Pregabalin; Treatment Outcome | 2021 |
Capsaicin-induced depolymerization of axonal microtubules mediates analgesia for trigeminal neuropathic pain.
Topics: Animals; Capsaicin; Chronic Pain; Hyperalgesia; Mice; Microtubules; Neuralgia; Paclitaxel; Trigeminal Neuralgia; TRPV Cation Channels; Tubulin | 2022 |
Modulation of excitatory synaptic transmissions by TRPV1 in the spinal trigeminal subnucleus caudalis neurons of neuropathic pain rats.
Topics: Animals; Capsaicin; Chronic Pain; Disease Models, Animal; Excitatory Postsynaptic Potentials; Facial Pain; Humans; Male; Neuralgia; Neurons; Rats; Synaptic Transmission; Trigeminal Caudal Nucleus; TRPV Cation Channels | 2021 |
Capsaicin 8% Dermal Patch for Neuropathic Pain in a Pain Unit.
Topics: Capsaicin; Humans; Neuralgia; Quality of Life; Retrospective Studies; Transdermal Patch | 2022 |
Sensory testing and topical capsaicin can characterize patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Capsaicin; Humans; Inflammation; Middle Aged; Neuralgia; Sensory System Agents | 2022 |
Participation of Potential Transient Receptors in the Antinociceptive Effect of Pharmacopuncture.
Topics: Acupuncture; Analgesics; Animals; Capsaicin; Male; Menthol; Neuralgia; Pain Measurement; Rats; Rats, Wistar | 2022 |
Capsaicin 8% for Peripheral Neuropathic Pain Treatment: A Retrospective Cohort Study.
Topics: Capsaicin; Humans; Neuralgia; Quality of Life; Retrospective Studies; Transdermal Patch | 2022 |
TRPV1 drugs alter core body temperature via central projections of primary afferent sensory neurons.
Topics: Animals; Body Temperature; Calcitonin Gene-Related Peptide; Capsaicin; Humans; Neuralgia; Sensory Receptor Cells; TRPV Cation Channels | 2022 |
Pain relief after topical capsaicin: does it result from nociceptor degeneration or regeneration?
Topics: Administration, Topical; Capsaicin; Humans; Neuralgia; Nociceptors; Pain Management; Regeneration | 2023 |
Small Synthetic Hyaluronan Disaccharide BIS014 Mitigates Neuropathic Pain in Mice.
Topics: Animals; Capsaicin; Gabapentin; Hyaluronic Acid; Hyperalgesia; Mice; Neuralgia; TRPV Cation Channels | 2023 |
Second-degree burn induced by high-concentration topical capsaicin with mobility sequelae: A case report.
Topics: Administration, Topical; Burns; Capsaicin; Female; Humans; Neuralgia | 2023 |
Diosgenin Exerts Analgesic Effects by Antagonizing the Selective Inhibition of Transient Receptor Potential Vanilloid 1 in a Mouse Model of Neuropathic Pain.
Topics: Analgesics; Animals; Capsaicin; CHO Cells; Cricetinae; Cricetulus; Diosgenin; Disease Models, Animal; Ganglia, Spinal; Hyperalgesia; Mice; Neuralgia; TRPV Cation Channels | 2022 |
Effects of Mirogabalin on Hyperalgesia and Chronic Ocular Pain in Tear-Deficient Dry-Eye Rats.
Topics: Animals; Capsaicin; Chronic Pain; Dry Eye Syndromes; Eye Pain; Female; Hyperalgesia; Neuralgia; Rats; Rats, Sprague-Dawley; Tears | 2023 |
[Long-term effectiveness of topical analgesics].
Topics: Administration, Topical; Analgesics; Botulinum Toxins, Type A; Capsaicin; Female; Humans; Lidocaine; Male; Neuralgia | 2020 |
Effects of gabapentinoids on responses of primary cultures from rat dorsal root ganglia to inflammatory or somatosensory stimuli.
Topics: Analgesics; Animals; Capsaicin; Female; Gabapentin; Ganglia, Spinal; Inflammation; Lipopolysaccharides; Male; Neuralgia; Neurons; Pregabalin; Primary Cell Culture; Rats; Rats, Wistar; Sensory System Agents; Somatosensory Cortex | 2020 |
Using transdermal patches to treat neuropathic pain.
Topics: Anesthetics, Local; Capsaicin; Humans; Lidocaine; Neuralgia; Patient Education as Topic; Transdermal Patch | 2020 |
Peripheral Neuropathy Associated with Hypereosinophilic Syndrome: A Clinical Therapeutic Success with Capsaicin 8% Patch.
Topics: Capsaicin; Humans; Hypereosinophilic Syndrome; Male; Middle Aged; Neuralgia; Pain Management; Peripheral Nervous System Diseases; Quality of Life; Transdermal Patch | 2020 |
Analgesic effects of the CTK 01512-2 toxin in different models of orofacial pain in rats.
Topics: Analgesics; Animals; Calcium Channels, N-Type; Capsaicin; Disease Models, Animal; Facial Pain; Freund's Adjuvant; Glutamic Acid; Hyperalgesia; Male; Neuralgia; omega-Conotoxins; Pain Measurement; Rats; Rats, Wistar; TRPA1 Cation Channel | 2020 |
Facial and Oral Cross-Contamination of a 3-Year-Old Child With High Concentration Capsaicin: A Case Report.
Topics: Capsaicin; Child, Preschool; Female; Humans; Neuralgia; Tongue | 2020 |
KM-416, a novel phenoxyalkylaminoalkanol derivative with anticonvulsant properties exerts analgesic, local anesthetic, and antidepressant-like activities. Pharmacodynamic, pharmacokinetic, and forced degradation studies.
Topics: Analgesics; Anesthetics, Local; Animals; Anticonvulsants; Antidepressive Agents; Area Under Curve; Brain; Capsaicin; Diabetic Neuropathies; Drug Stability; Epilepsy; Guinea Pigs; Hemodynamics; Male; Mice; Neuralgia; Pain Measurement; Patch-Clamp Techniques; Rats; Rats, Wistar; Sodium Channel Blockers | 2020 |
Antiallodynic effect of PhAR-DBH-Me involves cannabinoid and TRPV1 receptors.
Topics: Animals; Antineoplastic Agents; Arachidonic Acids; Azabicyclo Compounds; Cannabinoid Receptor Antagonists; Capsaicin; Cisplatin; Endocannabinoids; Female; Hyperalgesia; Injections, Intraperitoneal; Ligation; Models, Animal; Neuralgia; Oleic Acids; Polyunsaturated Alkamides; Rats; Rats, Wistar; Spinal Nerves; TRPV Cation Channels; Vagus Nerve Stimulation | 2020 |
8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Capsaicin; Child; Chronic Pain; Female; Humans; Male; Middle Aged; Neuralgia; Pain Management; Quality of Life; Retrospective Studies; Transdermal Patch; Treatment Outcome; Young Adult | 2020 |
CB
Topics: Animals; Cannabinoid Receptor Antagonists; Capsaicin; Cerebral Cortex; Disease Models, Animal; Excitatory Amino Acid Antagonists; Male; Neuralgia; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; TRPV Cation Channels | 2020 |
The Input-Output Relation of Primary Nociceptive Neurons is Determined by the Morphology of the Peripheral Nociceptive Terminals.
Topics: Action Potentials; Capsaicin; Computer Simulation; Humans; Models, Neurological; Neuralgia; Nociception; Nociceptors; Peripheral Nerves; Peripheral Nervous System Diseases; Presynaptic Terminals; Sensory Receptor Cells; Sodium Channels; Synaptic Transmission | 2020 |
Dermatopharmacokinetic and pharmacodynamic evaluation of a novel nanostructured formulation containing capsaicinoids for treating neuropathic pain.
Topics: Capsaicin; Chitosan; Humans; Hydrogels; Nanocapsules; Neuralgia | 2021 |
CGRP monoclonal antibody prevents the loss of diffuse noxious inhibitory controls (DNIC) in a mouse model of post-traumatic headache.
Topics: Animals; Antibodies, Monoclonal; Brain Concussion; Calcitonin; Calcitonin Gene-Related Peptide; Capsaicin; Chronic Pain; Diffuse Noxious Inhibitory Control; Disease Models, Animal; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Neuralgia; Post-Traumatic Headache | 2021 |
Impact of Hepatoma-Derived Growth Factor Blockade on Resiniferatoxin-Induced Neuropathy.
Topics: Animals; Astrocytes; Capsaicin; Diterpenes; Ganglia, Spinal; Hyperalgesia; Intercellular Signaling Peptides and Proteins; Male; Neuralgia; Neurons; Rats, Sprague-Dawley; Spinal Cord | 2021 |
Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.
Topics: Animals; Arachidonic Acids; Capsaicin; Constriction; Disease Models, Animal; Endocannabinoids; Hyperalgesia; Indoles; Male; Neuralgia; Pain Measurement; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rotarod Performance Test; Spinal Cord; TRPV Cation Channels | 2021 |
Post Laparoscopy Neuropathic Pain Treated by Capsaicin 8% Dermal Patch.
Topics: Capsaicin; Female; Humans; Laparoscopy; Middle Aged; Neuralgia; Transdermal Patch | 2021 |
Progressive Response to Repeat Application of Capsaicin 179 mg (8% w/w) Cutaneous Patch in Peripheral Neuropathic Pain: Comprehensive New Analysis and Clinical Implications.
Topics: Capsaicin; Humans; Neuralgia; Prospective Studies; Quality of Life; Transdermal Patch; Treatment Outcome | 2021 |
A preliminary prospective observational study of the effectiveness of high-concentration capsaicin cutaneous patch in the management of chronic post-surgical neuropathic pain.
Topics: Analgesics; Capsaicin; Humans; Neuralgia; Pain, Postoperative; Prospective Studies | 2022 |
Use of capsaicin for the treatment of localized neuropathic pain post-thoracotomy.
Topics: Capsaicin; Humans; Neuralgia; Pain Measurement; Thoracotomy | 2021 |
During capsaicin-induced central sensitization, brush allodynia is associated with baseline warmth sensitivity, whereas mechanical hyperalgesia is associated with painful mechanical sensibility, anxiety and somatization.
Topics: Anxiety; Capsaicin; Central Nervous System Sensitization; Humans; Hyperalgesia; Male; Neuralgia; Pain Threshold; Reproducibility of Results | 2021 |
A novel therapeutic with two SNAP-25 inactivating proteases shows long-lasting anti-hyperalgesic activity in a rat model of neuropathic pain.
Topics: Animals; Botulinum Toxins; Calcitonin Gene-Related Peptide; Capsaicin; Cells, Cultured; Disease Models, Animal; Hyperalgesia; Male; Models, Molecular; Motor Activity; Neuralgia; Peptide Hydrolases; Pregabalin; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Sensory Receptor Cells; Synaptosomal-Associated Protein 25; Time Factors; Trigeminal Ganglion | 2017 |
Vincristine-induced peripheral neuropathic pain and expression of transient receptor potential vanilloid 1 in rat.
Topics: Animals; Antineoplastic Agents, Phytogenic; Capsaicin; Disease Models, Animal; Dose-Response Relationship, Drug; Ganglia, Spinal; Gene Expression; Humans; Male; Neuralgia; Neurons; Rats, Wistar; Ruthenium Red; TRPV Cation Channels; Up-Regulation; Vincristine | 2017 |
Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.
Topics: Administration, Cutaneous; Adult; Aged; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pruritus; Quality of Life; Radiculopathy; Spine; Surveys and Questionnaires; Treatment Outcome | 2017 |
Differential effect of Incobotulinumtoxin A on pain, neurogenic flare and hyperalgesia in human surrogate models of neurogenic pain.
Topics: Adult; Botulinum Toxins, Type A; Capsaicin; Electric Stimulation; Female; Hot Temperature; Humans; Hyperalgesia; Injections, Intradermal; Male; Nerve Fibers, Unmyelinated; Neuralgia; Neuromuscular Agents; Pain Measurement; Pain Threshold; Sensory System Agents; Young Adult | 2017 |
The spider toxin Phα1β recombinant possesses strong analgesic activity.
Topics: Analgesics, Non-Narcotic; Animals; Calcium Channel Blockers; Capsaicin; Formaldehyde; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neuralgia; Nociceptive Pain; Rats, Wistar; Recombinant Proteins; Sciatic Nerve; Spider Venoms | 2017 |
High-concentration topical capsaicin in the management of refractory neuropathic pain in patients with neurofibromatosis type 1: a case series.
Topics: Administration, Topical; Adult; Analgesics; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Neurofibromatosis 1; Pain Management | 2018 |
Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics; Capsaicin; Denmark; Female; Health Status; Humans; Male; Middle Aged; Neuralgia; Norway; Pain Management; Prospective Studies; Quality of Life; Sweden; Transdermal Patch; Treatment Outcome; Young Adult | 2018 |
Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models.
Topics: Adult; Aged; Algorithms; Capsaicin; Female; Healthy Volunteers; Humans; Hyperalgesia; Lidocaine; Male; Middle Aged; Models, Biological; Nerve Block; Neuralgia; Pain Measurement; Pain Perception; Pain Threshold; Phenotype; Sensation; Sensory System Agents; Young Adult | 2018 |
Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
Topics: Administration, Cutaneous; Aged; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Neuralgia, Postherpetic; Pain Measurement; Retrospective Studies; Sensory System Agents; Transdermal Patch; Treatment Outcome | 2018 |
Nefopam downregulates autophagy and c-Jun N-terminal kinase activity in the regulation of neuropathic pain development following spinal nerve ligation.
Topics: Animals; Autophagy; Capsaicin; Cell Line, Tumor; Down-Regulation; Humans; JNK Mitogen-Activated Protein Kinases; Ligation; Lymphocytes; Male; Microtubule-Associated Proteins; Nefopam; Neuralgia; Oligodendroglia; Pain Measurement; Rats; Sequestosome-1 Protein; Spinal Cord; Spinal Nerves; Substantia Gelatinosa | 2018 |
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.
Topics: Action Potentials; Animals; Anxiety; Cannabidiol; Capsaicin; Disease Models, Animal; Exploratory Behavior; Feeding Behavior; Ganglia, Spinal; Hyperalgesia; Lysergic Acid Diethylamide; Male; Maze Learning; Neuralgia; Piperazines; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Swimming | 2019 |
Diosmetin as a novel transient receptor potential vanilloid 1 antagonist with antinociceptive activity in mice.
Topics: Analgesics; Animals; Calcium; Capsaicin; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Flavonoids; Inflammation; Male; Mice; Neuralgia; Pain; Pain Measurement; Spinal Cord; Synaptosomes; Toxicity Tests; TRPV Cation Channels | 2019 |
Mechanical allodynia and enhanced responses to capsaicin are mediated by PI3K in a paclitaxel model of peripheral neuropathy.
Topics: Animals; Capsaicin; Excitatory Postsynaptic Potentials; Hyperalgesia; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Neuralgia; Oncogene Protein v-akt; Paclitaxel; Peptide Fragments; Phosphatidylinositol 3-Kinases; Posterior Horn Cells; Protein Kinase C; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Signal Transduction; Spinal Cord; Toll-Like Receptor 4; Transient Receptor Potential Channels; TRPV Cation Channels | 2019 |
QAPSA: post-marketing surveillance of capsaicin 8% patch for long-term use in patients with peripheral neuropathic pain in France.
Topics: Adult; Aged; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Product Surveillance, Postmarketing; Prospective Studies; Quality of Life | 2019 |
Overexpression of P2X3 and P2X7 Receptors and TRPV1 Channels in Adrenomedullary Chromaffin Cells in a Rat Model of Neuropathic Pain.
Topics: Acetylcholine; Adenosine Triphosphate; Adrenal Medulla; Animals; Capsaicin; Catecholamines; Chromaffin Cells; Disease Models, Animal; Evoked Potentials; Exocytosis; Ganglia, Spinal; Male; Membrane Potentials; Neuralgia; Neurons; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X3; Receptors, Purinergic P2X7; TRPV Cation Channels | 2019 |
Patients' Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice.
Topics: Activities of Daily Living; Adult; Aged; Analgesics; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Clinics; Pain Management; Pain Measurement; Prospective Studies; Quality of Life; Transdermal Patch; Treatment Outcome | 2019 |
Phα1β toxin prevents capsaicin-induced nociceptive behavior and mechanical hypersensitivity without acting on TRPV1 channels.
Topics: Analgesics, Non-Narcotic; Animals; Behavior, Animal; Calcium Signaling; Capsaicin; Cells, Cultured; Disease Models, Animal; Ganglia, Spinal; HEK293 Cells; Humans; Insect Proteins; Male; Membrane Transport Modulators; Nerve Tissue Proteins; Neuralgia; Neurons; Peptides; Rats; Rats, Wistar; Recombinant Proteins; Spider Venoms; TRPV Cation Channels | 2013 |
The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
Topics: Capsaicin; Failed Back Surgery Syndrome; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neuralgia; Neuralgia, Postherpetic; Pain Management; Pain Measurement; Radiculopathy; Retrospective Studies; Sensory System Agents; Transdermal Patch; Treatment Outcome; Trigeminal Neuralgia | 2013 |
Operant behavioral responses to orofacial cold stimuli in rats with chronic constrictive trigeminal nerve injury: effects of menthol and capsazepine.
Topics: Animals; Behavior, Animal; Capsaicin; Cold Temperature; Conditioning, Operant; Facial Nerve; Facial Pain; Hyperalgesia; Male; Menthol; Neuralgia; Pain Measurement; Physical Stimulation; Rats; Rats, Sprague-Dawley; Trigeminal Nerve; Trigeminal Nerve Injuries; TRPM Cation Channels | 2013 |
Qutenza patch--our early experience.
Topics: Activities of Daily Living; Analgesics; Capsaicin; Chronic Pain; Humans; Neuralgia; Pain Measurement; Sleep; Surveys and Questionnaires; Transdermal Patch; Treatment Outcome | 2013 |
Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary?
Topics: Analgesics; Analgesics, Opioid; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Dipyrone; Female; Humans; Lidocaine; Male; Middle Aged; Neuralgia; Pain Measurement; Pirinitramide; Time Factors; Transdermal Patch; Treatment Outcome | 2014 |
Impaired neuropathic pain and preserved acute pain in rats overexpressing voltage-gated potassium channel subunit Kv1.2 in primary afferent neurons.
Topics: Acute Pain; Animals; Capsaicin; Ganglia, Spinal; HEK293 Cells; Humans; Kv1.2 Potassium Channel; Ligation; Male; Motor Activity; Neuralgia; Neurons, Afferent; Nociception; Peripheral Nerve Injuries; Protein Transport; Rats; Rats, Sprague-Dawley; RNA, Antisense; RNA, Messenger; Spinal Nerves; Time Factors; Transfection; Up-Regulation | 2014 |
Low-concentration topical capsaicin for chronic neuropathic pain in adults.
Topics: Administration, Topical; Adult; Capsaicin; Chronic Pain; Humans; Neuralgia | 2014 |
Intraganglionar resiniferatoxin prevents orofacial inflammatory and neuropathic hyperalgesia.
Topics: Animals; Capsaicin; Carrageenan; Cold Temperature; Disease Models, Animal; Diterpenes; Facial Pain; Formaldehyde; Hot Temperature; Hyperalgesia; Male; Neuralgia; Neurons; Nociception; Rats; Rats, Wistar; Sensory System Agents; Trigeminal Ganglion; TRPV Cation Channels | 2014 |
Citral: a monoterpene with prophylactic and therapeutic anti-nociceptive effects in experimental models of acute and chronic pain.
Topics: Acute Pain; Acyclic Monoterpenes; Analgesics; Animals; Capsaicin; Chronic Pain; Excitatory Amino Acids; Formaldehyde; Glutamic Acid; Hyperalgesia; Ischemia; Ketanserin; Male; Mice; Monoterpenes; Neuralgia; Pain, Postoperative; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Stomach Ulcer; Substance P; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2014 |
New insights into mechanisms of opioid inhibitory effects on capsaicin-induced TRPV1 activity during painful diabetic neuropathy.
Topics: Animals; Blood Glucose; Capsaicin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Male; Membrane Potentials; Nerve Growth Factor; Neuralgia; Rats, Wistar; Receptors, Opioid, mu; Sensory Receptor Cells; Spinal Cord; TRPV Cation Channels | 2014 |
LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic pain.
Topics: Administration, Oral; Animals; Capsaicin; Carrageenan; Disease Models, Animal; Enzyme Activation; Female; Hydrogen-Ion Concentration; Hyperalgesia; Imidazoles; Inflammation; Macrophages, Peritoneal; MAP Kinase Signaling System; Mice, Inbred BALB C; Neuralgia; Neutrophil Infiltration; Oocytes; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Time Factors; TRPV Cation Channels; Tumor Necrosis Factor-alpha; Xenopus laevis | 2014 |
Application of the capsaicin 8% cutaneous patch in neuropathic pain of the head and face: A case series.
Topics: Aged; Capsaicin; Face; Female; Head; Humans; Male; Middle Aged; Neuralgia; Sensory System Agents; Transdermal Patch; Young Adult | 2015 |
Expectations and positive emotional feelings accompany reductions in ongoing and evoked neuropathic pain following placebo interventions.
Topics: Adult; Aged; Anesthetics, Local; Capsaicin; Emotions; Female; Humans; Lidocaine; Male; Middle Aged; Neuralgia; Nocebo Effect; Pain Measurement; Physical Stimulation; Placebo Effect; Postoperative Complications; Psychological Tests; Sensory System Agents; Thoracostomy | 2014 |
Topical capsaicin response as a phenotypic measure in patients with pain.
Topics: Adolescent; Adult; Aged; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Management; Phenotype; Sensory System Agents; Young Adult | 2015 |
Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPARγ mechanisms.
Topics: Analysis of Variance; Animal Diseases; Animals; Area Under Curve; Astrocytes; Capsaicin; Glial Fibrillary Acidic Protein; Hyperalgesia; Hypoglycemic Agents; Injections, Intraventricular; Male; Neuralgia; Nociception; Oncogene Proteins v-fos; Pain Threshold; Pioglitazone; PPAR gamma; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn; Thiazolidinediones | 2015 |
Pattern of neuropathic pain induced by topical capsaicin application in healthy subjects.
Topics: Adolescent; Adult; Bayes Theorem; Capsaicin; Female; Healthy Volunteers; Humans; Male; Neuralgia; Pain Measurement; Pain Threshold; Sensation; Sensory System Agents; Young Adult | 2015 |
Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice.
Topics: Acetanilides; Analgesics; Animals; Benzamides; Capsaicin; Cold Temperature; Disease Models, Animal; Formaldehyde; Hyperalgesia; Isothiocyanates; Male; Mice; Neuralgia; Oximes; Paclitaxel; Pain Measurement; Purines; Thiophenes; Touch; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPM Cation Channels; TRPV Cation Channels | 2015 |
Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain.
Topics: Adult; Aged; Antipruritics; Capsaicin; Female; Humans; Hyperalgesia; Male; Middle Aged; Nerve Fibers, Unmyelinated; Neuralgia; Outcome Assessment, Health Care; Prognosis | 2016 |
Capsaicin 8% Patch for Central and Peripheral Neuropathic Pain of Persons with Incomplete Spinal Cord Injury: Two Case Reports.
Topics: Adult; Aged; Capsaicin; Humans; Hyperalgesia; Male; Neuralgia; Pain Measurement; Sensory System Agents; Spinal Cord Injuries; Transdermal Patch | 2015 |
Can topical capsaicin induce a neuropathic pain?
Topics: Capsaicin; Female; Humans; Male; Neuralgia; Sensory System Agents | 2015 |
Reply to "Can topical capsaicin induce a neuropathic pain?".
Topics: Capsaicin; Female; Humans; Male; Neuralgia; Sensory System Agents | 2015 |
Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade.
Topics: Adult; Aged; Anesthetics, Local; Animals; Antineoplastic Agents; Capsaicin; Diabetic Neuropathies; Female; Flagellin; Ganglia, Spinal; Humans; Hyperalgesia; Lidocaine; Male; Mice; Mice, Knockout; Middle Aged; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Neuralgia; Neurofilament Proteins; Neurons; Paclitaxel; Peripheral Nerve Injuries; Sensory System Agents; Toll-Like Receptor 5 | 2015 |
TRPV1 channel modulation by hyaluronan reduces pain.
Topics: Action Potentials; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Capsaicin; Extracellular Matrix; HEK293 Cells; Hot Temperature; Humans; Hyaluronic Acid; Inflammation; Injections, Intra-Articular; Ion Channel Gating; Knee Joint; Neuralgia; TRPV Cation Channels | 2016 |
[Topical ambroxol for the treatment of neuropathic pain: A first clinical observation. German version].
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Ambroxol; Capsaicin; Female; Humans; Lidocaine; Long-Term Care; Male; Middle Aged; Neuralgia; Pain Measurement; Pain, Postoperative; Retrospective Studies | 2015 |
Nonparalytic botulinum molecules for the control of pain.
Topics: Animals; Botulinum Toxins, Type A; Capsaicin; Cell Count; Cell Proliferation; Disease Models, Animal; Freund's Adjuvant; Ganglia, Spinal; Hyperalgesia; Inflammation; Keratinocytes; Male; Motor Activity; Nerve Fibers, Unmyelinated; Neuralgia; Neuromuscular Agents; Pain Measurement; Pain Threshold; Pain, Postoperative; Rats; Rats, Sprague-Dawley; Spinal Cord Dorsal Horn | 2016 |
Contribution of capsaicin-sensitive primary afferents to mechanical hyperalgesia induced by ventral root transection in rats: the possible role of BDNF.
Topics: Animals; Brain-Derived Neurotrophic Factor; Capsaicin; Disease Models, Animal; Hyperalgesia; Male; Neuralgia; Pain Threshold; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Sensory System Agents; Spinal Nerve Roots; Statistics, Nonparametric; Transfection | 2016 |
Amitriptyline, but Not Pregabalin, Reverses the Attenuation of Noxious Stimulus-Induced Analgesia After Nerve Injury in Rats.
Topics: Adrenergic Neurons; Amitriptyline; Analgesics; Animals; Behavior, Animal; Capsaicin; Disease Models, Animal; Microdialysis; Neuralgia; Norepinephrine; Pain Threshold; Peripheral Nerve Injuries; Pregabalin; Rats; Rats, Sprague-Dawley; Reaction Time; Sensory System Agents; Spinal Nerves; Time Factors | 2016 |
Pruritic hyperpigmented patch on back.
Topics: Administration, Topical; Aged; Antipruritics; Back Pain; Capsaicin; Female; Humans; Neuralgia; Paresthesia; Pruritus; Treatment Outcome | 2016 |
Antinociceptive activity and mechanism of action of hydroalcoholic extract and dichloromethane fraction of Amphilophium crucigerum seeds in mice.
Topics: Analgesics; Animals; Bignoniaceae; Binding, Competitive; Calcium Signaling; Capsaicin; Chronic Pain; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Ethanol; Male; Methylene Chloride; Mice; Neuralgia; Nociception; Nociceptive Pain; Pain Measurement; Phytotherapy; Plant Extracts; Plants, Medicinal; Protein Binding; Seeds; Signal Transduction; Solvents; Spinal Cord; Synaptosomes; TRPV Cation Channels | 2017 |
Consistent sex-dependent effects of PKMζ gene ablation and pharmacological inhibition on the maintenance of referred pain.
Topics: Animals; Capsaicin; Cell-Penetrating Peptides; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Freund's Adjuvant; Inflammation; Lipopeptides; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuralgia; Pain Threshold; Piperidines; Protein Kinase C; Rats; Rats, Long-Evans; Sex Characteristics; Spinal Cord | 2016 |
SHANK3 Deficiency Impairs Heat Hyperalgesia and TRPV1 Signaling in Primary Sensory Neurons.
Topics: Animals; Behavior, Animal; Blotting, Western; Capsaicin; Ganglia, Spinal; Humans; Hyperalgesia; Immunohistochemistry; Inflammation; Mice; Mice, Knockout; Microfilament Proteins; NAV1.8 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Neuralgia; Pain; Patch-Clamp Techniques; Presynaptic Terminals; Reverse Transcriptase Polymerase Chain Reaction; Sensory Receptor Cells; Sensory System Agents; Spinal Cord; TRPV Cation Channels | 2016 |
The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
Topics: Administration, Topical; Adult; Aged; Capsaicin; Cohort Studies; Female; Humans; Ischemia; Kidney Failure, Chronic; Male; Middle Aged; Neuralgia; Peripheral Vascular Diseases; Sensory System Agents; Transdermal Patch | 2017 |
Residual spinothalamic tract pathways predict development of central pain after spinal cord injury.
Topics: Adult; Capsaicin; Cold Temperature; Female; Histamine; Hot Temperature; Humans; Male; Menthol; Middle Aged; Nerve Fibers; Neuralgia; Nociceptors; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Prognosis; Sensation; Spinal Cord Injuries; Spinothalamic Tracts | 2008 |
Interleukin-1alpha regulates substance P expression and release in adult sensory neurons.
Topics: Age Factors; Animals; Capsaicin; Cells, Cultured; Female; Ganglia, Spinal; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1alpha; Interleukin-1beta; Nerve Growth Factor; Neuralgia; Nociceptors; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Sensory System Agents; Substance P; Up-Regulation | 2009 |
NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain.
Topics: Administration, Cutaneous; Analgesics, Non-Narcotic; Animals; Capsaicin; Clinical Trials as Topic; Drugs, Investigational; Humans; Molecular Structure; Neuralgia; Patents as Topic; Structure-Activity Relationship | 2009 |
[Types of topical treatment for peripheral neuropathic pain : Mechanism of action and indications].
Topics: Administration, Topical; Afferent Pathways; Analgesics; Anesthetics, Local; Antidepressive Agents; Capsaicin; Humans; Lidocaine; Nerve Fibers; Nerve Regeneration; Neuralgia; Peripheral Nervous System Diseases; Sensory System Agents; TRPV Cation Channels | 2010 |
Capsaicin. Neuropathic pain: playing with fire....
Topics: Administration, Cutaneous; Capsaicin; Clinical Trials as Topic; Humans; Neuralgia; Sensory System Agents | 2010 |
Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
Topics: Analgesics; Animals; Benzamides; Capsaicin; Fever; HEK293 Cells; Humans; Male; Neuralgia; Pain; Pain Measurement; Protein Binding; Quinolones; Rats; Rats, Sprague-Dawley; TRPV Cation Channels | 2011 |
Nociceptive cortical responses during capsaicin-induced tactile allodynia in mice with spinal dorsal column lesioning.
Topics: Animals; Capsaicin; Functional Laterality; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Neuralgia; Sensory System Agents; Somatosensory Cortex; Spinal Cord | 2011 |
Peripheral nerve stimulation in intractable neuropathic pain.
Topics: Administration, Cutaneous; Adult; Capsaicin; Electric Stimulation Therapy; Electrodes, Implanted; Female; Humans; Neuralgia; Neurologic Examination; Neurosurgery; Peripheral Nerves; Ulnar Nerve; Ulnar Neuropathies | 2011 |
Intrathecal administration of AS1928370, a transient receptor potential vanilloid 1 antagonist, attenuates mechanical allodynia in a mouse model of neuropathic pain.
Topics: Animals; Benzamides; Capsaicin; Disease Models, Animal; Hyperalgesia; Injections, Spinal; Mice; Neuralgia; Quinolones; Tissue Distribution; TRPV Cation Channels | 2011 |
Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain.
Topics: Analysis of Variance; Anilides; Animals; Ankyrins; Antineoplastic Agents, Phytogenic; Capsaicin; Carbazoles; Central Nervous System; Cinnamates; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Estrenes; Gene Expression Regulation; Hyperalgesia; Male; Mice; Mice, Inbred ICR; Neuralgia; Oligopeptides; Paclitaxel; Pain Measurement; Physical Stimulation; Protein Kinase C; Pyrroles; Pyrrolidinones; Receptor, PAR-2; Sulfonamides; Time Factors; TRPV Cation Channels; Tryptases; Type C Phospholipases | 2011 |
Role of peripheral versus spinal 5-HT(7) receptors in the modulation of pain undersensitizing conditions.
Topics: 2-Hydroxyphenethylamine; Administration, Oral; Analysis of Variance; Animals; Capsaicin; Denervation; Dose-Response Relationship, Drug; Foot; Injections; Injections, Spinal; Male; Neuralgia; Pain; Pain Measurement; Peripheral Nerves; Physical Stimulation; Pyrazoles; Rats; Rats, Wistar; Receptors, Serotonin; Sciatic Neuropathy; Serotonin Receptor Agonists; Spinal Cord | 2012 |
Spinal glycinergic and GABAergic neurons expressing C-fos after capsaicin stimulation are increased in rats with contralateral neuropathic pain.
Topics: Animals; Capsaicin; Freund's Adjuvant; Functional Laterality; GABAergic Neurons; Glycine; Inflammation; Male; Molecular Imaging; Neuralgia; Neurons; Pain; Pain Threshold; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Spinal Cord | 2011 |
Suppressive effects of glycyrrhetinic acid derivatives on tachykinin receptor activation and hyperalgesia.
Topics: Analgesics; Animals; Calcium; Capsaicin; CHO Cells; Cricetinae; Disease Models, Animal; Formaldehyde; Glycyrrhetinic Acid; Hot Temperature; Humans; Hyperalgesia; Inflammation; Ligation; Male; Neuralgia; Neurokinin A; Neurokinin B; Pain; Rats; Rats, Sprague-Dawley; Receptors, Tachykinin; Sciatic Nerve; Substance P | 2011 |
Plasma corticosterone levels in mouse models of pain.
Topics: Adjuvants, Immunologic; Animals; Capsaicin; Carrageenan; Corticosterone; Disease Models, Animal; Freund's Adjuvant; Habituation, Psychophysiologic; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neuralgia; Nociceptors; Pituitary-Adrenal System; Sciatica; Sensory System Agents; Species Specificity; Stress, Physiological | 2012 |
The combined predictive capacity of rat models of algogen-induced and neuropathic hypersensitivity to clinically used analgesics varies with nociceptive endpoint and consideration of locomotor function.
Topics: Amines; Analgesics; Animals; Capsaicin; Cyclohexanecarboxylic Acids; Disease Models, Animal; Duloxetine Hydrochloride; Exploratory Behavior; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Hyperalgesia; Locomotion; Male; Morphine; Neuralgia; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Thiophenes | 2012 |
Discovery of novel 5,5-diarylpentadienamides as orally available transient receptor potential vanilloid 1 (TRPV1) antagonists.
Topics: Alkadienes; Amides; Analgesics; Animals; Blood-Brain Barrier; Calcium; Capsaicin; Dogs; Epstein-Barr Virus Nuclear Antigens; Haplorhini; HEK293 Cells; Humans; Hyperalgesia; Male; Microsomes, Liver; Neuralgia; Quinolones; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; TRPV Cation Channels | 2012 |
Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization.
Topics: Analgesics; Animals; Behavior, Animal; Capsaicin; Electric Stimulation; Formaldehyde; Gene Expression Regulation; Male; Mice; Morpholines; Neuralgia; Pain Measurement; Pyrazoles; Receptors, sigma; Sigma-1 Receptor | 2012 |
Intractable neuropathic pain in spinal intramedullary cavernoma treated successfully with a novel combination cream.
Topics: Capsaicin; Drug Combinations; Humans; Isosorbide Dinitrate; Lidocaine; Male; Middle Aged; Neuralgia; Ointments; Pain, Intractable; Spinal Cord Neoplasms | 2012 |
Palvanil, a non-pungent capsaicin analogue, inhibits inflammatory and neuropathic pain with little effects on bronchopulmonary function and body temperature.
Topics: Analgesics; Animals; Body Temperature; Bronchoconstriction; Capsaicin; Edema; Female; Hyperalgesia; Hypothermia; Inflammation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neuralgia; Pain Measurement; Respiratory System; Sciatic Nerve; TRPV Cation Channels | 2012 |
Regulation of Wnt signaling by nociceptive input in animal models.
Topics: Animals; beta Catenin; Capsaicin; Disease Models, Animal; Ganglia, Spinal; HIV Envelope Protein gp120; Male; Mice; Mice, Inbred C57BL; Neuralgia; Nociception; Posterior Horn Cells; Protein Transport; Up-Regulation; Wnt Proteins; Wnt Signaling Pathway; Wnt-5a Protein; Wnt3A Protein | 2012 |
Differential effects of peripheral versus central coadministration of QX-314 and capsaicin on neuropathic pain in rats.
Topics: Anesthetics, Local; Animals; Antipruritics; Capsaicin; Disease Models, Animal; Drug Administration Routes; Drug Therapy, Combination; Hyperalgesia; Lidocaine; Male; Neuralgia; Peripheral Nerves; Rats; Rats, Sprague-Dawley | 2012 |
Role of capsaicin-sensitive C-fiber afferents in neuropathic pain-induced synaptic potentiation in the nociceptive amygdala.
Topics: Afferent Pathways; Amygdala; Animals; Capsaicin; Female; Male; Nerve Fibers, Unmyelinated; Neuralgia; Nociceptors; Pain Threshold; Rats; Rats, Wistar; Synaptic Transmission | 2012 |
Inhibitory control of nociceptive responses of trigeminal spinal nucleus cells by somatosensory corticofugal projection in rat.
Topics: Action Potentials; Afferent Pathways; Animals; Bicuculline; Biophysics; Capsaicin; Constriction; Disease Models, Animal; Electric Stimulation; Female; GABA-A Receptor Antagonists; Glutamic Acid; Glycine Agents; Hyperalgesia; Iontophoresis; Male; Neural Inhibition; Neuralgia; Nociceptors; Pain; Physical Stimulation; Rats; Rats, Sprague-Dawley; Somatosensory Cortex; Strychnine; Time Factors; Trigeminal Nucleus, Spinal | 2012 |
2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent transient receptor potential vanilloid 1 (TRPV1) antagonists: structure-activity relationships of 2-amino derivatives in the N-(6-trifluoromethylpyridin-3-ylmethyl) C-region.
Topics: Analgesics; Animals; Body Temperature; Capsaicin; CHO Cells; Cricetinae; Cricetulus; Dopamine; Hot Temperature; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Docking Simulation; Neuralgia; Pyridines; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Sulfonamides; TRPV Cation Channels | 2012 |
Expression of TRPV1 channels after nerve injury provides an essential delivery tool for neuropathic pain attenuation.
Topics: Anesthetics, Local; Animals; Capsaicin; Gene Expression; Hyperalgesia; Lidocaine; Male; Mandibular Nerve; Myelin Sheath; Nerve Regeneration; Neuralgia; Nociceptors; Pain Management; Pain Threshold; Rats; Rats, Sprague-Dawley; Trigeminal Ganglion; Trigeminal Nerve Injuries; TRPV Cation Channels | 2012 |
[Practical information about Qutenza patch: capsaicin "reloaded"].
Topics: Analgesics, Non-Narcotic; Capsaicin; Humans; Neuralgia; Transdermal Patch | 2012 |
Runx1 controls terminal morphology and mechanosensitivity of VGLUT3-expressing C-mechanoreceptors.
Topics: Amino Acid Transport Systems, Acidic; Animals; Behavior, Animal; Capsaicin; Core Binding Factor Alpha 2 Subunit; Hyperalgesia; Ion Channels; Mechanoreceptors; Mice; Mice, Knockout; Nerve Endings; Neuralgia; Physical Stimulation; Skin; Tyrosine 3-Monooxygenase | 2013 |
Effects of peripheral nerve injury on functional spinal VR1 receptors.
Topics: Action Potentials; Animals; Capsaicin; Denervation; Dose-Response Relationship, Drug; Down-Regulation; Hyperalgesia; Ligation; Nerve Fibers; Nerve Fibers, Myelinated; Neuralgia; Neuronal Plasticity; Nociceptors; Pain Threshold; Peripheral Nerve Injuries; Peripheral Nerves; Peripheral Nervous System Diseases; Physical Stimulation; Posterior Horn Cells; Rats; Receptors, Drug | 2002 |
Enhanced release of adenosine in rat hind paw following spinal nerve ligation: involvement of capsaicin-sensitive sensory afferents.
Topics: Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Adenosine Kinase; Afferent Pathways; Animals; Capsaicin; Disease Models, Animal; Enzyme Inhibitors; Hyperalgesia; Male; Nerve Crush; Nerve Fibers, Unmyelinated; Neuralgia; Neurons, Afferent; Nociceptors; Oxidopamine; Peripheral Nerve Injuries; Peripheral Nerves; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Skin; Spinal Nerves; Sympathetic Fibers, Postganglionic | 2002 |
Aftersensations in experimental and clinical hypersensitivity.
Topics: Adult; Aged; Aged, 80 and over; Capsaicin; Female; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Pain; Pain Measurement; Pain Threshold; Peripheral Nerve Injuries; Physical Stimulation; Time Factors; Wounds and Injuries | 2003 |
[Pain and QOL--morphine-tolerance and morphine-resistant neuropathic pain].
Topics: Adrenergic alpha-Antagonists; Capsaicin; Drug Resistance; Drug Therapy, Combination; Drug Tolerance; Humans; Morphine; Neoplasms; Neuralgia; Phentolamine; Protein Kinase C; Quality of Life; Receptor, trkB; Receptors, N-Methyl-D-Aspartate | 2003 |
Topical capsaicin for saphenous neuralgia.
Topics: Administration, Topical; Aged; Aged, 80 and over; Capsaicin; Coronary Artery Bypass; Femoral Nerve; Humans; Male; Neuralgia; Saphenous Vein; Tissue and Organ Harvesting | 2003 |
Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation.
Topics: Afferent Pathways; Analgesics, Opioid; Animals; Calcitonin Gene-Related Peptide; Capsaicin; Disease Models, Animal; Dynorphins; Enkephalins; Hyperesthesia; Ligation; Lumbosacral Region; Male; Medulla Oblongata; Microinjections; N-Glycosyl Hydrolases; Nerve Compression Syndromes; Neuralgia; Neuronal Plasticity; Neurotransmitter Agents; Oligopeptides; Opioid Peptides; Pain Measurement; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Recombinant Fusion Proteins; Ribosome Inactivating Proteins, Type 1; Saporins; Sensory Thresholds; Spinal Cord; Spinal Nerves | 2003 |
Neuropathy treatment shows promise.
Topics: Capsaicin; Drug Delivery Systems; HIV Infections; Humans; Neuralgia | 2004 |
Stimulus-evoked release of neuropeptides is enhanced in sensory neurons from mice with a heterozygous mutation of the Nf1 gene.
Topics: Afferent Pathways; Animals; Calcitonin Gene-Related Peptide; Capsaicin; Cells, Cultured; Ganglia, Spinal; Heterozygote; Hyperalgesia; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Growth Factor; Neuralgia; Neurofibromatosis 1; Neurons, Afferent; Neuropeptides; Organ Culture Techniques; Pain Threshold; Posterior Horn Cells; Presynaptic Terminals; Proto-Oncogene Proteins p21(ras); Substance P; Synaptic Transmission | 2006 |
Roles of capsaicin-sensitive primary afferents in differential rat models of inflammatory pain: a systematic comparative study in conscious rats.
Topics: Analgesics, Non-Narcotic; Animals; Bee Venoms; Behavior, Animal; Capsaicin; Carrageenan; Edema; Formaldehyde; Hot Temperature; Hyperalgesia; Injections, Subcutaneous; Irritants; Male; Neuralgia; Neuritis; Neurons, Afferent; Nociceptors; Physical Stimulation; Rats; Rats, Sprague-Dawley; Reaction Time | 2007 |
Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats.
Topics: Analgesics; Animals; Avoidance Learning; Azepines; Benzazepines; Capsaicin; Central Nervous System; Drinking; Histamine Agonists; Histamine Antagonists; Humans; Male; Memory Disorders; Neuralgia; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Histamine H3; Scopolamine | 2007 |
Use of capsaicin in the treatment of radicular pain in spinal cord injury.
Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Measurement; Retrospective Studies; Spinal Cord Injuries; Treatment Outcome | 2000 |
Adlea (ALGRX-4975), an injectable capsaicin (TRPV1 receptor agonist) formulation for longlasting pain relief.
Topics: Analgesics; Animals; Capsaicin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Injections; Neuralgia; Pain; Pain, Postoperative; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; TRPV Cation Channels | 2008 |
Local application of capsaicin alleviates mechanical hyperalgesia after spinal nerve transection.
Topics: Analgesics; Animals; Biomarkers; Calcitonin Gene-Related Peptide; Capsaicin; Cell Count; Denervation; Ganglia, Spinal; Hyperalgesia; Male; Nerve Degeneration; Neuralgia; Neurons, Afferent; Pain Measurement; Peripheral Nerve Injuries; Peripheral Nerves; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Sprague-Dawley; Sensory System Agents; TRPV Cation Channels | 2008 |
Pain and hyperalgesia in acute inflammatory and chronic neuropathic conditions.
Topics: Acute Disease; Capsaicin; Chronic Disease; Humans; Neuralgia; Pain | 1995 |
Capsaicin-induced flare and vasodilatation in patients with post-herpetic neuralgia.
Topics: Administration, Topical; Afferent Pathways; Aged; Axons; Capsaicin; Case-Control Studies; Edema; Female; Herpes Zoster; Humans; Male; Middle Aged; Nerve Fibers; Neuralgia; Nociceptors; Pain Threshold; Vasodilator Agents | 1995 |
Pruritus circumscriptus sine materia: a sequel of postzosteric neuralgia. Evaluation by quantitative psychophysical examination and laser-evoked potentials.
Topics: Aged; Capsaicin; Evoked Potentials; Female; Herpes Zoster; Humans; Lasers; Neuralgia; Neurodermatitis; Pain Measurement; Pruritus; Psychophysics | 1996 |
Responses of adult human dorsal root ganglion neurons in culture to capsaicin and low pH.
Topics: Action Potentials; Adult; Back Pain; Capsaicin; Cell Size; Cells, Cultured; Electrophysiology; Female; Ganglia, Spinal; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Neural Conduction; Neuralgia; Neurofibromatoses; Neurons; Pain; Patch-Clamp Techniques; Scoliosis | 1996 |
The use of capsaicin in herpes zoster ophthalmicus neuralgia.
Topics: Administration, Topical; Aged; Capsaicin; Female; Follow-Up Studies; Herpes Zoster Ophthalmicus; Humans; Male; Middle Aged; Neuralgia; Ointments; Substance P | 1997 |
Treatments for postherpetic neuralgia.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Capsaicin; Desipramine; Herpes Zoster; Humans; Meta-Analysis as Topic; Neuralgia; Reproducibility of Results; Treatment Outcome | 1997 |
Submodality-selective hyperalgesia adjacent to partially injured sciatic nerve in the rat is dependent on capsaicin-sensitive afferent fibers and independent of collateral sprouting or a dorsal root reflex.
Topics: Animals; Capsaicin; Extravasation of Diagnostic and Therapeutic Materials; Formaldehyde; Ganglia, Spinal; Hindlimb; Hot Temperature; Hyperalgesia; Immersion; Male; Mechanoreceptors; Nerve Fibers; Nerve Regeneration; Neuralgia; Neurites; Neurons, Afferent; Nociceptors; Physical Stimulation; Plasma; Rats; Rats, Wistar; Reflex; Sciatic Nerve | 1997 |
Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones?
Topics: Animals; Capsaicin; Disease Models, Animal; Functional Laterality; Hot Temperature; Hyperalgesia; Male; Neuralgia; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Sciatica | 1999 |
Non-noxious A fiber afferent input enhances capsaicin-induced mechanical hyperalgesia in the rat.
Topics: Animals; Behavior, Animal; Capsaicin; Electric Stimulation; Hyperalgesia; Male; Nerve Fibers, Myelinated; Neuralgia; Physical Stimulation; Rats; Rats, Sprague-Dawley | 2001 |
Neurogenic hyperalgesia versus painful hypoalgesia: two distinct mechanisms of neuropathic pain.
Topics: Adult; Aged; Capsaicin; Central Nervous System Diseases; Cold Temperature; Female; Hot Temperature; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Neurons, Afferent; Pain Threshold; Peripheral Nervous System Diseases; Touch | 2002 |
[Neuropathic pain; causes and treatment].
Topics: Administration, Topical; Capsaicin; Humans; Neuralgia | 1992 |
[Capsaicin and neurogenic pain: a new use for an old substance].
Topics: Capsaicin; Humans; Nerve Endings; Neuralgia; Nociceptors; Pain; Pain, Intractable; Synaptic Transmission | 1991 |
Argon laser induced cutaneous sensory and pain thresholds in post-herpetic neuralgia. Quantitative modulation by topical capsaicin.
Topics: Administration, Topical; Aged; Aged, 80 and over; Capsaicin; Female; Herpes Zoster; Humans; Male; Middle Aged; Neuralgia; Sensory Thresholds | 1990 |
The measurement of capsaicin-sensitive sensory nerve fiber function in elderly patients with pain.
Topics: Aged; Back Pain; Capsaicin; Female; Herpesviridae Infections; Humans; Lasers; Male; Nerve Fibers; Neuralgia; Pain; Pain Measurement; Psychometrics; Psychophysiologic Disorders; Regional Blood Flow; Reproducibility of Results; Self Concept; Sensation | 1990 |
[The treatment of post-herpetic neuralgia using capsaicin ointment].
Topics: Capsaicin; Herpes Zoster; Humans; Neuralgia; Ointments | 1990 |
Capsaicin in the treatment of dermatologic disease.
Topics: Capsaicin; Herpes Zoster; Humans; Neuralgia; Ointments; Psoriasis; Substance P | 1987 |
Treatment of oral postherpetic neuralgia with topical capsaicin.
Topics: Administration, Topical; Aged; Capsaicin; Herpes Zoster; Humans; Male; Mouth Mucosa; Neuralgia; Substance P | 1988 |
Post-herpetic neuralgia and topical capsaicin.
Topics: Administration, Topical; Adult; Aged; Capsaicin; Female; Follow-Up Studies; Herpes Zoster; Humans; Male; Middle Aged; Neuralgia; Palliative Care; Paresthesia; Patient Dropouts; Sensation | 1988 |
Treatment of painful diabetic neuropathy with topical capsaicin.
Topics: Aged; Capsaicin; Diabetic Neuropathies; Humans; Male; Middle Aged; Neuralgia; Ointments | 1989 |
Successful treatment of postherpetic neuralgia with capsaicin.
Topics: Administration, Topical; Aged; Analgesics; Capsaicin; Eyelids; Face; Female; Herpes Zoster Ophthalmicus; Humans; Neuralgia; Skin | 1988 |
Effects of topical capsaicin on normal skin and affected dermatomes in herpes zoster.
Topics: Administration, Topical; Aged; Aged, 80 and over; Capsaicin; Herpes Zoster; Hot Temperature; Humans; Middle Aged; Neuralgia; Sensory Thresholds; Skin Diseases | 1988 |
Varicella-zoster virus infection.
Topics: Acyclovir; Capsaicin; Herpes Zoster; Humans; Neuralgia | 1988 |
Topical capsaicin for treatment of neuralgia associated with herpes zoster infection.
Topics: Administration, Topical; Capsaicin; Female; Herpes Zoster; Humans; Middle Aged; Neuralgia | 1988 |
Treatment of chronic postherpetic neuralgia with topical capsaicin. A preliminary study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Capsaicin; Female; Herpes Zoster; Humans; Male; Middle Aged; Neuralgia | 1987 |